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Allergic rhinitis, chronic rhinosinusitis, and asthma are highly prevalent, multifactorial
chronic airway diseases. Several environmental and genetic factors affect airway
epithelial dynamics leading to activation of inflammatory mechanisms in the airways.
This review links environmental factors to host epithelial immunity in airway diseases.
Understanding altered homeostasis of the airway epithelium might provide important
targets for diagnostics and therapy of chronic airway diseases.
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BULLET POINTS
Chronic airway diseases are mediated by several, in part unknown, host epithelial- and environment
dependent mechanisms.
- The typical disease-leading host-environmental effects are on mucociliary clearance and other
innate immunity functions of the epithelial barrier (such as epithelial junctions, pattern
recognition, self-renewal, activation of adaptive immunity, metabolism).
- In AR, allergens are able to penetrate airway mucosa by their proteolytic, lipid-binding, and
microbial-mimicking properties through the epithelial cells and/or between them.
- Airway viral infections have been implicated in development and exacerbations of AR and
asthma, however, their role in CRS pathogenesis remains unclear.
- Airborne irritants, such as cigarette smoke, disrupt epithelial junction proteins and
transepithelial resistance, and contribute to CRS alone or together with viral infection.
- Air pollutants might predispose to CRS via aberrant epithelial function.
- Microbiome dysbiosis likely contributes to CRS pathogenesis.
- S. aureus colonization indirectly/directly affects mucosal barrier function, leading to a Th2 type
inflammation pattern.
- The role of fungi has been shown in at least two CRS phenotypes, fungal balls, and allergic fungal
rhinosinusitis (AFRS).
INTRODUCTION
In allergic rhinitis (AR), allergens bind to specific immunoglobulin (Ig)E, leading to rhinorrhea,
obstruction, itch, sneeze, and fatigue in sensitized subjects (Wise et al., 2018). AR is interlinked
to co-morbidities including asthma, allergic conjunctivitis and atopic dermatitis. However, its
role in chronic rhinosinusitis (CRS) is not clear. Chronic inflammation, mucus hypersecretion,
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edema, variable obstruction, and fatigue characterize asthma.
In both children and adults, asthma encompasses different,
overlapping phenotypes (Wenzel, 2012; Kaur and Chupp,
2019). Allergic multi-morbidity and predominance in males
characterize childhood-onset asthma, whereas adult-onset
asthma is more common in females and includes a wide
variety of allergic [T helper (Th) Type 2 (Th2)-high] and non-
allergic (often Th1-high) phenotypes (Wenzel, 2012; Frohlich
et al., 2017). Severe eosinophilic forms, e.g., non-steroidal
anti-inflammatory drug (NSAID-) exacerbated respiratory
disease (NERD), are more common in adults. So far, only few
encouraging signals have been found in asthma prevention. The
problem may be over-simplification of terminology. Asthma is
not a single disease entity, but rather a complex, heterogeneous,
and dynamic immunological disorder strongly influenced by
gene – environment interactions.
AR and asthma affect over 300 million people worldwide,
thus being major public health problems (Gupta et al., 2004;
Nunes et al., 2017; GINA, 2018). The prevalence of AR is 15–
50% (Pallasaho et al., 2006; Wiksten et al., 2018), its prevalence
at teen-age is 13–38% (Pols et al., 2016; Blaiss et al., 2018; Sterner
et al., 2019). The prevalence and socioeconomic impact are
difficult to calculate since mild symptoms do not require medical
treatment, and most patients outgrow their (especially food)
allergies. The prevalence and incidence of, particularly childhood,
asthma varies greatly in different parts of the world. After many
decades of continuously increasing asthma rates in the Western
world, we seem to have reached a plateau in asthma incidence
since the beginning of 2000 in many developed countries. In some
places even a decrease has been observed. Children migrating
from low-income areas to higher socioeconomic areas have a
lower prevalence of asthma, suggesting a critical time window for
asthma onset in childhood. This suggests the possibility of asthma
prevention, since there appear to be predisposing biological
factors influenced by the environment. On the other hand, it is
likely that within a population, there are genetic factors limiting
the number of asthmatics. It should be kept in mind that up to
85% of asthma patients have AR, and on the other hand, 15–38%
of AR patients have asthma (Mésidor et al., 2019). Of adults with
asthma, 80% have rhinitis, and 50% have chronic rhinosinusitis
(Jarvis et al., 2012).
Chronic rhinosinusitis (CRS) is a chronic symptomatic
inflammation of the sinonasal tract, with a prevalence of 3–
10% (Fokkens et al., 2012; Dietz de Loos et al., 2019; Hirsch
et al., 2019). CRS presents with (CRSwNP) or without (CRSsNP)
nasal polyps (NP), and is defined by typical subjective symptoms
(facial pain, post-nasal drip, obstruction, discharge) lasting for
at least 12 weeks, objectively confirmed by either positive
endoscopic findings (oedema, mucus secretions, polyps) or
positive radiologic findings (mucosal inflammation on sinus CT
scans). NERD tends to lead to more severe forms of CRS,
with NPs and asthma.
The pathomechanisms of asthma, CRS and AR are related
to genetic predisposition and aberrant host-immune interactions
during development. The environment strongly affects gene
expression by epigenetic mechanisms. In addition to genetic
predisposition, climate change, population growth, aging, and
urbanization impact the increasing prevalence of chronic airway
diseases (Kaur and Chupp, 2019).
Genetics and environmental factors can, during development,
significantly modulate barrier homeostasis, influencing the
predilection toward chronic airway inflammation. The
respiratory epithelium is a part of the innate and adaptive
immune system, with responsibility for several functions such as
mucociliary clearance, pattern recognition, phagocytosis, antigen
presentation, signaling, and self-renewal. Airway epithelial
dysfunction is related to several airway diseases. The main
focus of this review are the pathomechanisms of human airway
epithelium in AR, CRS, and asthma. We also briefly discuss
altered airway epithelium in bronchiectasis, primary ciliary
dyskinesia (PCD), and cystic fibrosis (CF).
GENOME-SCALE EPITHELIAL FACTORS
BEHIND AIRWAY DISEASES
Adult-onset asthma is mediated by activation of molecular
pathways leading to persistent mucosal inflammation, variable
airway obstruction, inflammation, and tissue remodeling.
Genetic and epigenetic variation of the host play key roles (Willis-
Owen et al., 2018), and airway dysbiosis may be an important
trigger (Huang et al., 2015). Childhood-onset asthma appears
to be triggered by allergic and infective immune responses, and
barrier dysfunction, with a stronger genetic component and
higher heritability (Pividori et al., 2019; Schoettler et al., 2019).
Genome-wide association studies (GWAS)s have focused on
childhood-onset allergic asthma, and the currently identified
single nucleotide polymorphisms (SNP)s thus seem to have
lower significance in adult-onset asthma (Pividori et al., 2019).
Candidate genes for asthma include interleukin (IL)-4, IL-13
and IL-4R, ADRB2, MS4A2, tumor necrosis factor α (TNFα),
cluster of differentiation (CD)14, human leukocyte antigen
(HLA)-DRB1 and HLA-DQB1 (Toskala and Kennedy, 2015;
Willis-Owen et al., 2018). Combined GWAS and transcriptome-
wide association tests have identified several genetic loci that may
be relevant in asthma, such as the chromosome 17q locus, HLA,
IL-6, interferon regulatory factor 4 (IRF4), chemokine (C-C
motif) ligand 20 (CCL20), mucin 5AC (MUC5AC), fatty acid
desaturase 2 (FADS2), T-box transcription factor 21 (TBX21),
runt-related transcription factor 1 (RUNX1), and cytokine and
chemokine receptors and signaling molecules (Pividori et al.,
2019; Vercelli and Bleecker, 2019). A study showed that asthma
remission is associated with genes related to Th2-mediated
inflammation, such as IL1RL1-, IL18R1-, and IL-13 (Vonk
et al., 2018). A singular GWAS study of a Japanese adult-onset
asthma population showed that SNPs of HLA-, thymic stromal
lymphopoietin-WD repeat domain 36 (TSLP-WDR36)-, and
ubiquitin specific peptidase 38-GRB2 associated binding protein
1 (USP38-GAB1) loci are associated with adult-onset asthma
(Hirota et al., 2011).
A missense variant in arachidonate 15-lipoxygenase
(ALOX15) is protective against the development of CRSwNP
(Kristjansson et al., 2019). In nasal epithelial cells, IL-13
upregulates ALOX15 and promotes eoxtaxin 3 expression,
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likely promoting tissue eosinophilia in CRSwNP patients (Li
et al., 2019). This pathway may also have a role in epithelial
remodeling and barrier dysfunction (Kristjansson et al., 2019).
Our transcriptomics of healthy middle turbinate epithelium
showed that 75% of protein encoding genes are expressed,
suggesting that the epithelium is a very active organ (Hanif et al.,
2019). The importance of barrier-environmental interactions
was detected also in a single cell transcriptomics study of nasal
epithelium, demonstrating that basal cell memory of Type
2 inflammation leads to persistent dysfunction in CRSwNP
patients (Ordovas-Montanes et al., 2018).
Multi-gene expression-based biomarkers of asthma were
studied in a Network-identified Transcription Factor –
framework (Ahsen et al., 2019). ETS translocation variant (ETV4)
and Peroxisome proliferator-activated receptor gamma (PPARG)
were identified as being the most significant transcription factors.
The group further performed validation studies using a nasal
epithelium cell line in which both transcription factors were
knocked down by siRNA. The respective cell lines produced a
significantly decreased amount of IL-8 and IL-6, before poly (I:C)
stimulation and before (Ahsen et al., 2019).
EPITHELIAL DYNAMICS IN UPPER
AIRWAY DISEASES
Airway barriers likely have a key role in the development of CRS
and AR. In AR, mucosal inflammation is triggered by allergens,
together with other environmental factors, leading to IgE-
mediated mucosal inflammation. In CRS, mucosal inflammation
is triggered by a dysfunctional interaction between exogenous
agents and the immune system (Liao et al., 2014; Lam et al.,
2015; Hoggard et al., 2017). Compared to AR, there is larger
inter- and intra-individual variation in the causal factors behind
CRS (Figure 1).
Environmental Factors and Upper Airway
Epithelium
Allergen entry into airway mucosa is facilitated by several
allergen-, host-, and environment-dependent mechanisms.
Allergens are able to penetrate airway mucosa by their
proteolytic, lipid-binding, and microbial-mimicking properties
(Toppila-Salmi et al., 2015). Mite allergen entry has shown to
be facilitated by altered pattern recognition pathways (Lam
et al., 2015). Our study group has shown that birch pollen
allergens (Bet v1) are able to bind plasma membrane lipid
rafts (Toppila-Salmi et al., 2015) and to be transported in
caveolar vesicles through the nasal epithelium until they reach
mast cells. However, this was detected in allergic patients only
(Joenvaara et al., 2009). Moreover, natural birch exposure
causes transcriptomics alterations in controls; the fold changes
were detected in the nasal epithelial transcripts belonging to
Gene Ontology (GO) –category “Immunology”. In contrast,
transcripts of the AR group were enriched in “Response to virus”
and “Cellular transportation” –categories (Mattila et al., 2010).
Similar categories have been demonstrated in grass pollen allergy
(Roschmann et al., 2011). We performed whole transcriptomic
sequencing of nasal epithelial brush samples and demonstrated
that birch pollen allergen immunotherapy alters the transcript
profile during pollen exposure season toward that of control
samples (Hanif et al., 2019). Moreover, the data showed that
in AR patients who started with subcutaneous birch pollen
immunotherapy, microbiome diversity of nasal epithelium
shifted toward that of controls (Hanif et al., 2019).
AR has been shown to associated with active/passive smoking
(Saulyte et al., 2014). Taken together, in AR, airborne allergens,
as well as tobacco smoke, microbes, and air pollutants are related
to the development and aggravation of the disease (Saulyte et al.,
2014; Wiksten et al., 2018).
In prevention of CRS development and its progression,
commensal organisms likely play a protective role by preventing
mucosal colonization by pathogens and putatively providing
metabolites improving mucosal health. It has been assumed that
microbial agents and microbiome dysbiosis are some of the most
important drivers of CRS pathogenesis. S. aureus can directly
affect mucosal barrier function and drive Type 2 inflammation
(Ryu and Kim, 2020). Molecular sequencing techniques are
evolving in power and enable studies on total and relative
microbial abundance and their functional activity within the
sinonasal tract (Earl et al., 2018). Yet it is important to note
intra- and inter-individual variation of the samples and sites
of sampling (Copeland et al., 2018). In a cross-sectional study
involving sequencing of the V3-V4 region of the 16S ribosomal
RNA (rRNA) gene in nasal samples, decreased middle meatal
microbiome diversity was detected in AR, CRSsNP, and CRSwNP
groups compared to controls, with high variability in microbe
profiles and even within subjects (Lal et al., 2017). Hence, recent
studies support the hypothesis that dysbiosis of the microbiome
may trigger mucosal inflammation both in AR and in CRS
(Knight et al., 2018). Airway viral infections have been implicated
in development and exacerbations of AR and asthma, however,
their role in CRS pathogenesis remains unclear. In addition, the
role of fungi has been shown in at least two CRS phenotypes,
fungal balls and allergic fungal rhinosinusitis (AFRS).
Cigarette smoke extract has been shown to disrupt epithelial
junction proteins and transepithelial resistance in an epithelial
sinonasal model derived from control patient samples (Tharakan
et al., 2016). In addition, cigarette smoke and viral infection might
contribute to polyp remodeling (Yamin et al., 2015). Decreased
levels of airway epithelial clara cell protein 16 (CC16) are found
in the nasal secretions and plasma of patients with CRS and in
subjects exposed to high levels of air pollutants (Peric et al., 2018).
There is some evidence that heavy metal exposure is related to
CRS (Khlifi et al., 2015).
Upper Airway Epithelial Functions During
AR and CRS
The upper airway barrier provides several important innate
immunity functions, blockage of microbe entry, and recruitment
of leukocytes. Airway epithelium plays a critical role in
conducting and humidifying air, responding to trigeminal and
olfactory stimuli, and in host defense. The airway epithelial
barrier comprises ciliated cells, olfactory cells (in olfactory
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FIGURE 1 | Epithelial dynamics in upper and lower airway epithelium; normal epithelium and epithelium in allergic rhinitis, chronic rhinosinusitis, and asthma. APC,
Antigen-presenting cell; ILC, innate lymphoid cell; PPR, pattern recognition receptor; PAMP, pathogen-associated molecular pattern; DAMP, danger-associated
molecular pattern; MCC, mucociliary clearance; TJ, tight junction; t-PA, tissue plasminogen activator; ZO, zonula occludin; EMT, epithelial-mesenchymal transition;
MMP, matrix metalloproteinase; SP, surfactant protein; UPR, unfolded protein response.
epithelium), mucus-secreting goblet cells, basal cells with
progenitor capacity (Bravo et al., 2013) and few chemosensory
cells (Kohanski et al., 2018).
Motile cilia consist of microtubules and dynein arms, powered
by adenosine triphosphate (ATP) (Knowles et al., 2013; Popatia
et al., 2014). Coordinated ciliary beating transports debris-
laden mucus from respiratory passages toward the oropharynx
(Toppila-Salmi et al., 2015). Genetic and acquired defects in
mucociliary flow with increased mucus viscosity are associated
with a high incidence of CRS (Cutting, 2005; Gudis et al., 2012).
Cilia are coated with mucins and tethered mucopolysaccharides
(Toppila-Salmi et al., 2015). Li Y. Y. et al. (2014) detected
cilia abnormalities in CRSwNP (Jiao et al., 2015), and that
impaired ciliated epithelial differentiation may be mediated via
decreased interferon gamma (IFNγ) and IL-13 levels leading to
secondary declines in ciliary beat frequency (Jiao et al., 2015).
Reduced expression of WDPCP, a ciliogenesis protein, due to
inflammatory cytokines resulted in impaired ciliogenesis and
cilia function in CRS patients (Ma et al., 2017). Secretory cells
produce polymeric gel-forming mucins, such as MUC5AC and
MUC5B (Toppila-Salmi et al., 2015). Gel-forming mucins are
secreted into the airway lumen and are responsible for the
characteristic viscoelastic properties of the mucus gel layer.
Tipirneni et al. (2018) identified that dynamic mucus strand
velocities from submucosal glands, a major component of
mucociliary clearance, were significantly decreased in CRS.
Surfactant protein A gene expression has been shown to be
increased in CRS and decreased in primary atrophic rhinitis (El-
Anwar et al., 2015). In overview, CRS is commonly associated
with mucociliary dysfunction.
Both epithelial specification and terminal differentiation
are critical to epithelial homeostasis in airway diseases
(Ordovas-Montanes et al., 2018). Environmental and mucosal
signals regulate epithelial stem-cell self-renewal under normal
conditions (Yilmaz et al., 2012) and in CRS (Ordovas-Montanes
et al., 2018). Under physiological conditions, environmental
and intrinsic signals are able to rapidly alter the composition
and function of the epithelium. A study group performed
single cell transcriptomics of polyps/scraping epithelium of
twelve CRSwNP and nine control subjects. They detected
differences in expression of antimicrobial genes by secretory
cells, a loss of glandular cell heterogeneity, and that polyp
basal progenitor cells were locked to a Type 2 memory
(Ordovas-Montanes et al., 2018). Epithelial basal progenitor cells
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are able to migrate and proliferate into ciliated and goblet cells in
injured regions.
Upper airway epithelium secretes several cytokines including
TSLP, IL-33, and IL-25. These cytokines are released by tissue
damage, pathogen recognition or allergen exposure. They effect
Th2 cell function either directly or via innate lymphoid cells
(ILCs), which in turn produce IL-5, IL-9, and IL-13 (Licona-
Limon et al., 2013; Scadding, 2014), related to Th2-type
CRS, asthma and AR (Toppila-Salmi et al., 2015). S. aureus
colonization is more common in patients with CRSwNP
than controls (Tomassen et al., 2016). S. aureus produces
serine protease-like protein (Spl), which causes Th2- biased
inflammatory responses via TSLP and IL-33 (Stentzel et al., 2017;
Ryu and Kim, 2020). S. aureus specific IgE has been associated
with both CRSwNP and asthma. S. aureus enterotoxins and
S. aureus Spls have been found to have allergenic properties
(Stentzel et al., 2017; Ryu and Kim, 2020). Type 2 cytokines
inhibit t-PA (tissue plasminogen activator) resulting in the
deposition of fibrin mesh to form the tissue matrix of NPs
(Takabayashi et al., 2013).
Pattern recognition receptors (PRRs) rapidly detect microbial
and other foreign molecular patterns and either maintain
homoeostasis or induce immune responses. Luukkainen et al.
(2018) stimulated a co-culture of peripheral blood mononuclear
cells and nasal epithelium, differentiated from stem/progenitor
cells, with H3N2-virus and detected rapid activation of
monocytes, natural killer (NK)-cells and innate T-cells (MAIT
and γδ T cells). We demonstrated high baseline nasal epithelial
expression of Toll Like receptor (TLR) proteins (TLR1-7, TLR9-
10) and MyD88 both in AR and in controls (Renkonen et al.,
2015). After off-seasonal intranasal birch pollen challenge, a
negative change in the expression score of TLR1 and TLR6
proteins was detected in the atopic group. Tengroth et al. (2014b)
demonstrated abundant TLR3, TLR7, TLR9, RIG-I, and MDA-
5 in nasal epithelium. The group detected defects in TLR9-
mediated microbial defense in CRSwNP (Tengroth et al., 2014a).
Studies on polyp and control tissue show that increased epithelial
TLR2 (Sun et al., 2012) and TLR4 may be related with CRSwNP
(Sun et al., 2012; Shimizu et al., 2016; Hu and Li, 2018). Nasal
polyp fibroblast activation may occur via TLR2 (Shin et al.,
2016a,b; Tsai et al., 2018), TLR4 (Cho et al., 2014, 2016), TLR5
(Shin et al., 2016b), and TLR9 (Park et al., 2018) might be
related to polyp B-cell activation (Xu et al., 2014). NOD family
PRRs form a major component of the inflammasome, and are
related in programmed pro-inflammatory cell death distinct
from apoptosis. Jardeleza et al. (2013) detected involvement
of inflammasome complexes and their signaling pathways in
Staphylococcus aureus -biofilm positive CRSwNP. Lin et al.
(2016) detected increased NLRP3 and caspase-1 in eosinophilic
CRSwNP, and augmented inflammasome signaling pathway by
lipopolysaccharides (LPS). Bitter taste receptors (T2Rs) are G
protein-coupled receptors that function as non-classical PRRs.
Bacterial quinolones and acyl-homoserine lactones, secreted
by gram-negative bacteria, can activate airway T2R-mediated
immune responses (Lee and Cohen, 2014; Freund et al., 2018).
Linkage studies have demonstrated associations between taste
receptor genetics with CRS (Cohen, 2017).
Airway epithelium secretes defense molecules such as
surfactant, lactoferrin, and defensins, which kill or neutralize
microorganisms. Some evidence suggests that decreased
secretion of host defense molecules is associated with CRS
(Tieu et al., 2010). Decreased expression levels of palate, lung,
and nasal epithelium clone protein (PLUNC), and increased
surfactant-B and alpha-defensin levels have been observed in
CRSwNP, possibly secondary to loss of glands (Seshadri et al.,
2012; Jardeleza et al., 2013; Lin et al., 2016; Tsybikov et al., 2016).
Protease inhibitors regulate environmental proteases that
might compromise barrier integrity. Blocking protease allergens
with inhibitors reduces allergic responses in AR (Suzuki et al.,
2006). Fukuoka et al. (2019) showed that human cystatin SN,
an endogenous protease inhibitor, suppresses AR symptoms by
inhibiting allergen protease activities and by allergen-specifically
protecting nasal TJ barrier. Kouzaki et al. (2016) showed lower
host expression of two protease inhibitors (cystatin A and
SPINK5) in nasal epithelial cells extracted from patients with
eosinophilic CRS compared with control and non-eosinophilic
CRS groups. This suggests that an imbalance of proteases and
protease inhibitors within the epithelial barrier may contribute to
the pathogenesis of Type 2 diseases in general (Wu et al., 2018).
Epithelial cells undergo turnover and repair after injury
through epithelial to mesenchymal transition (EMT), with a rapid
and normally reversible modulation of the epithelial phenotype
toward mesenchymal cells (Toppila-Salmi et al., 2015). During
EMT, epithelial cells lose cell-cell polarity and adhesion to
become migratory. They get mesenchymal features such as
alpha-smooth muscle actin, vimentin, matrix metalloproteinases
(MMPs), and transcription factors. In CRS, aberrant epithelial
structure and function may lead to increased permeability to
foreign material suggesting this as an early factor in CRS
pathogenesis (Pothoven et al., 2015; Ramezanpour et al., 2016;
Suzuki et al., 2016; Jiao et al., 2019). Inflammation leads to
remodeling with cytokines, mediators, enzymes, and other factors
determining the remodeling pattern, not fully depending on
the CRS phenotype. The duration and type of inflammation
affect mucosal structure and function, and clinical severity of
inflammation. Remodeling changes of CRS include fibrosis,
basement membrane thickening (BMT), goblet cell hyperplasia,
epithelial barrier abnormalities and polyp formation, osteitis, and
angiogenesis (Barham et al., 2015; Kuhar et al., 2017).
Periostin promotes adhesion and migration of epithelial cells
and is associated with CRSwNP (Ishida et al., 2012; Ohta et al.,
2014; Laury et al., 2015; Milonski et al., 2015; Shiono et al.,
2015; Wang et al., 2015; Ebenezer et al., 2017; Xu et al., 2017;
Wei et al., 2018; Yang et al., 2018; Lehmann et al., 2019) and
asthma (Carpagnano et al., 2018; Wei et al., 2018). The EMT
process is driven by an array of factors such as WNT, reactive
oxygen species, proteases, HIF1, IL-13 Epiregulin, Oncostatin M,
and IL-1 (Oyer et al., 2013; Batzakakis et al., 2014; Schleimer,
2017; Aazami et al., 2018; Yang et al., 2018; Tomaszewska et al.,
2019). CRSwNP patients have altered expression levels of EMT
related factors, such as MMP-1 (Malinsky et al., 2013; Homma
et al., 2017), MMP-2 (Malinsky et al., 2013), TIMP-1 (Wang
et al., 2012; Muluk et al., 2015), MMP-7 (Yang et al., 2017; Chen
et al., 2018), MMP-9 (Wang et al., 2012; Malinsky et al., 2013;
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Yeo et al., 2013; Li et al., 2015; Muluk et al., 2015; Chen et al.,
2018; Suzuki et al., 2018; Xiang et al., 2019), TIMP-2 (Li et al.,
2015) E-cadherin (Hupin et al., 2014; Kim et al., 2018; Deng
et al., 2019). BMT is associated with duration of inflammation
independent of tissue eosinophilia (Kountakis et al., 2004; Kuhar
et al., 2017). TGF-β has been most closely linked to fibrosis,
but IL-13 and osteopontin have also been implicated in BMT
and fibrosis (Rehl et al., 2007; Van Bruaene and Bachert, 2011;
Shi et al., 2013; Schleimer and Berdnikovs, 2017). Abnormalities
of the coagulation cascade have also been associated with
polyp formation including Factor X, tissue factor and thrombin
(Shimizu et al., 2015; Shimizu et al., 2017; Takabayashi et al.,
2019). There is some evidence that stem cells in the epithelium
maintain a memory for the chronic immature EMT state in severe
Type 2 CRS (Lehmann et al., 2019), promoting barrier failure,
antigen access, and this inflammation (Pothoven and Schleimer,
2017). Type 2 cytokines inhibit t-PA activity so in the presence
of high levels of Type 2 inflammation, the matrix will be retained
and grow (Peterson et al., 2012).
Compared to the CRS phenotype, remodeling has been
less studied in patients with AR. Li and Li (2019) performed
transmission electron microscopy, western blot, and qPCR to
nasal epithelial samples of patients with AR and detected
increased autophagosomes, Beclin-1, LC3-II, and Collagen III,
along with increased symptom scores, suggesting a link between
autophagy and airway remodeling in AR. Taken together,
several epithelial phenomena take part in the development and
chronicity of the inflammation during CRS and AR.
Epithelial physical barriers are maintained by intercellular
junctions. Tight junctions (TJ) are located the most apically,
are linked to the cytoskeleton and inhibit solute and water
movement through the paracellular space, thus establishing
cell polarity (Toppila-Salmi et al., 2015). Inhaled allergens,
microbial or viral infections, cytokines, hypoxia, and zinc
deficiency are able to affect TJ molecules and epithelial barrier
function in the airways (Roscioli et al., 2017; Jiao et al., 2019).
Several genes/molecules, such as SPINK5, S100A7, S100A8/9,
PCDH1, NDRG1, SPRR, and p63 are involved in modulating
the physical barrier function in CRS (Jiao et al., 2019). Yu
et al. (2013) demonstrated decreased expression of Epithelium
membrane protein 1 (EMP1), a TJ protein, in nasal polyp
epithelium compared to control nasal mucosa. Soyka et al.
(2012) detected a decreased trans-tissue resistance in biopsy
specimens from patients with CRSwNP and also decreased TJ
proteins. Suzuki et al. (2016) detected that nasal polyp had
a higher expression of claudin (Cld)1 but lower expression
of tricellulin compared with the turbinate. Integrity of the
nasal epithelial TJ barrier has been shown to be compromised
in Chinese patients with eosinophilic and non-eosinophilic
CRSwNP transforming growth factor (TGF)-β1 seems to plays an
important role in inducing TJ barrier defects (Jiao et al., 2018). Li
et al. showed decreased expression of epithelial zonula occludin
(ZO)-1, Cld1, desmoglein (DSG)1, and DSG2 in CRSwNP and
decreased expression of Cld1, DSG1, and DSG2 in CRSsNP
(Li Y. et al., 2014).
Adherens junctions are located more basally than
TJs. Epithelial cadherin (E-cadherin) creates intercellular
interactions. Together, these junction proteins function to
limit intercellular passage of fluid and protect the underlying
tissue from exposure to noxious and allergenic stimuli (London
and Ramanathan, 2017). Epithelial cell communication is
mediated via Gap junction channels, which are formed by
connexin proteins enabling cell communication (Kim et al.,
2016). Expression of connexins have been demonstrated to be
increased in CRS compared to controls (Kim et al., 2016). Hence,
epithelial barrier dysfunction may contribute to AR and CRS
through allowing increased passage of antigens and exposure of
underlying tissue to these stimuli (Toppila-Salmi et al., 2015;
London and Ramanathan, 2017).
EPITHELIAL DYNAMICS IN LOWER
AIRWAY DISEASES
Ventilation moves air through the conducting airways to and
from the alveoli. The inhaled air contains respiratory gases,
particles, microbes, and toxins. Defense mechanisms preventing
the entry of unwanted substances into the lung tissue and
circulatory system include the branching structure of the
conducting airways, the layers of mucus covering the airways,
mucociliary clearance, contraction of the airway smooth muscle,
the tight adhesions of airway epithelial cells (AEC) and their
underlying stroma, and the production of host-defense molecules
regulated by exposure to toxins, pathogens and cytokines
(Lambrecht and Hammad, 2012; Whitsett and Alenghat, 2015).
Asthma is a chronic pulmonary disease characterized by
airway inflammation, airway hyperreactivity, and recurrent,
reversible airway obstruction. Several asthma phenotypes related
to disease mechanisms exist; these include childhood-onset
allergic asthma, adult-onset eosinophilic asthma, obesity-related
asthma, and neutrophilic asthma (Wenzel, 2012). Airway
inflammation is initiated by AECs as a defense against inhaled
pathogens and particles, e.g., allergens. In asthma these defense
mechanisms are hyperreactive. Excessive mucus production
contributes to airway obstruction, which is mainly caused by
contraction of airway smooth muscle (Erle and Sheppard, 2014;
Figure 1).
Environmental Factors, Epithelium, and
Asthma
The risk factors for asthma include AR and allergic conjunctivitis,
atopic dermatitis, exposure to air pollution, cigarette smoke,
occupational risk factors, obesity, and genetic factors (Polosa and
Thomson, 2013; Ilmarinen et al., 2015; Toskala and Kennedy,
2015; Willis-Owen et al., 2018; Toppila-Salmi et al., 2019).
Childhood-onset asthma has a stronger genetic component than
adult asthma and is triggered due to dysregulated allergy and
epithelial barrier function (Pividori et al., 2019; Schoettler et al.,
2019). The development of adult asthma is more likely in patients
with an accumulation of several risk factors and with allergic
multimorbidities (Hallit et al., 2019; Pividori et al., 2019; Toppila-
Salmi et al., 2019). Asthma, rhinitis, and chronic rhinosinusitis
often co-exist (Jarvis et al., 2012).
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The airway microbiome communicates with the respiratory
epithelium and has an important role in maintaining airway
health (Hansel et al., 2013; Morris et al., 2013; Huang et al.,
2015). Disruption of normal mucociliary clearance in smokers,
and in patients with asthma or cystic fibrosis (CF) affects
airway microbiome homeostasis and may lead to disease
(Dickson et al., 2013; Hansel et al., 2013; Morris et al., 2013).
Early childhood respiratory tract microbial exposure influences
immune responses, regulating Th1 and Th2 immunity and
affecting future asthmatic responses (Busse et al., 2010; Ege
et al., 2011). In children with a family history of asthma,
the risk of asthma is increased by severe respiratory syncytial
virus (RSV) infections (Sigurs et al., 2000). Virus infections
of the respiratory tract, especially caused by rhinoviruses,
associate with asthma exacerbations (Busse et al., 2010). Patients
with asthma may have deficient IFNγ response leading to
prolonged and more severe viral infections, deficient IFNγ
response has also been linked to Th2 type immune reaction
(Lisspers et al., 2018).
Epithelial Functions in Asthma
The trachea, bronchi, and bronchioles are mainly lined
by ciliated pseudostratified epithelium. Also serous, club,
goblet and neuroendocrine cells, and smooth muscle cells are
found in the airways.
In patients with asthma and bronchiectasis, excessive
goblet cell differentiation, and mucus production are common
(Whitsett and Alenghat, 2015).
Submucosal glands in the trachea and bronchi are lined
by basal, ciliated, myoepithelial, serous and goblet cells, and
secrete fluids and host-defense molecules such as lysozyme,
lactoferrin, human-b-defensins, and surfactant proteins A and
D. Mucins are large glycoproteins mainly produced by goblet
cells (mucin granules), they have important functions in cell-
cell interaction, EGFR signaling and airway protection (Thai
et al., 2008; Voynow and Rubin, 2009). Mucins tied to AECs
(MUC4, MUC13, MUC16, MUC21) create a barrier that by
pathogen or host-associated proteases can shed, enabling the
unwanted microbe to be removed by mucociliary clearance.
Secreted airway mucins (MUC5B, MUC5AC, and MUC2) form
a microbe binding, bacterial aggregation disrupting gel. The
expression of secreted mucins is induced by transcription factors
e.g., MAPK, STAT6, and inhibited by transcription factors
FOXa2 and TTF-1 (Maeda et al., 2011; Alevy et al., 2012;
Whitsett and Alenghat, 2015).
Dysfunctional movement of the cilia leads to impaired
mucociliary clearance, accumulation of thick mucus and
recurrent infections. Primary ciliary dyskinesia (PCD) patients
have structurally abnormal cilia, decreased production of nitric
oxide by AECs, bronchiectasis, and chronic bacterial infections
of both the upper and lower airways (Knowles et al., 2013;
Popatia et al., 2014). Secondary impairment of ciliary movement,
e.g., due to smoking or CF, leads to abnormalities in airway
hydration and mucus production. Ciliary function is influenced
by mechanical stress, inflammatory and neurochemical signals,
including paracrine signals of AECs. The gap junctions between
cells exchange responses induced by these stimuli, connexin
Cnx43 plays an important role in this (Martin and Prince, 2008;
Bou Saab et al., 2014).
The respiratory epithelium recognizes pathogen-associated
molecular patterns (PAMP), from commensal microbes or
pathogens, and danger-associated molecular patterns (DAMP),
from cell stress or cell death. Membrane associated or cytosolic
PRRs expressed in AECs recognize PAMPs and DAMPs,
resulting in signaling via TLRs, mitogen-activated protein
kinase (MAPK), IRF and nuclear factor-κB (NF-κB) family
transcription factors, reactive oxygen species (ROS), and Janus
kinase – signal transducer and activator of transcription (JAK-
STAT) signaling pathway, some of which also interact (Athari,
2019). The resulting cytokine and chemokine signaling and
production of antimicrobial proteins leads to recruitment
and activation of innate and adaptive immune system cells,
and regulation of barrier function (Voynow and Rubin,
2009; Lambrecht and Hammad, 2012; Erle and Sheppard,
2014; Whitsett and Alenghat, 2015). Also unfolded protein
response (UPR) helps in clearing pathogens and infection
by linking the synthesis of misfolded proteins encoded by
pathogens to inflammatory signaling, activating apoptosis and
necrosis to remove the pathogens and infected epithelial
cells (Osorio et al., 2013). Alveolar macrophages, but also
AECs ingest infected and apoptotic cells by phagocytosis
(Juncadella et al., 2013).
TLR4 can be activated by LPS, cigarette smoke, RSV, and
inflammatory cytokines (Monick et al., 2003; Armstrong et al.,
2004; Pace et al., 2008). Allergens cause TLR4-dependent
activation of NF-κBs, resulting in secretion of chemokines
and cytokines, such as IL-33, TSLP, and IL-25, and activation
and recruitment of pulmonary dendritic cells, Type 2 innate
lymphoid cells (ILC2 cells) and Th2 lymphocytes (Hammad
et al., 2009; Tan et al., 2010; Lambrecht and Hammad, 2014).
Interferons are secreted to defend against viral infections,
and in patients with asthma, deficient IFNγ response may
lead to prolonged and more severe viral infections (Lisspers
et al., 2018). A study group performed expression profiling
of airway epithelium that demonstrated similar cytokine
profiles of EGR1, DUSP1, FOSL1, JUN, MYC, and IL-6
after stimulation of AECs with either dsRNA or with house
dust mite, however, both triggers also induced a specific
response (e.g., ATF3, FOS, and NF-κB1) (Golebski et al.,
2014). It could thus be possible that microbial infection and
its underlying immune dysfunction might be a phenotypic
or clinical feature of both atopic and non-atopic chronic
conditions in the airways rather than only a secondary effect
(Juhn, 2014).
Epithelial extracellular vesicles (EVs) can transfer microRNAs
(miRNAs). In particular miR-34a, miR-92b, and miR-210 may
have a role in the development of the Th 2 response in asthma
(Bartel et al., 2019). As a sign of epithelial dysfunction in
asthma, AEC DNA methylation is different in asthmatics vs.
non-asthmatics (Clifford et al., 2019).
A recent study shows that asthmatic Type 2 inflammation
and airway hyperresponsiveness are related to mast cell
infiltration into the airway epithelium and that AECs and
mast cells communicate through IL-33 signaling that regulates
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inflammation (Altman et al., 2019). In allergic asthma, the
inflammatory process is initiated by Th2 cells that produce
cytokines, such as IL-4, IL-5, IL-9, IL-13, leading to the
production of IgE, eosinophilia, and goblet cell hyperplasia
(Whitsett and Alenghat, 2015; Athari, 2019). Pathways
to regulate goblet cell hyperplasia are also activated by
epidermal growth factor receptor (EGFR) (Tyner et al.,
2006). Contraction of the airway smooth muscle, resulting
in airway narrowing, is induced by acetylcholine released
from efferent parasympathetic nerves, or by histamine and
cysteinyl leukotrienes released from mast cells and basophils
(Erle and Sheppard, 2014). Asthma is modulated also by
Th9 and Th17 cells, that produce IL-17F, IL-22, and IL-17A
inducing airway inflammation and enhancing smooth muscle
contractility (Kudo et al., 2013). Airway epithelium and smooth
muscle cells communicate also via epithelial cell-derived
endothelin-1 (Lan et al., 2018). Airway hyperresponsiveness
is linked to IL-4 (Athari, 2019), and also to IL-13 and IL-
17 by inducing RhoA expression, and Ca2+ sensitization of
bronchial smooth muscle (Erle and Sheppard, 2014). Airway
smooth muscle contractibility is also increased by TNFα
(Goto et al., 2009).
The barriers created by AECs are important for the health and
normal function of the airways. Increased epithelial permeability
and inflammation with disruptions in the TJ complexes may
affect the pathogenesis of asthma and other pulmonary diseases
(Georas and Rezaee, 2014). Barriers of AECs include secretory
products, surface glycocalyces, membranes and intracellular
junction proteins consisting of claudins, connexins, paranexins,
adhesions, and ZOs. Pulmonary cells claudins, such as claudin
3 (Cld3), Cld4, and Cld18 create interlocking structures forming
these TJs (Whitsett and Alenghat, 2015).
The alveoli are lined by only two cell types, simple squamous
alveolar squamous epithelium type I (90%) or cuboidal type II
cells. The type II alveolar cells are the main progenitor cells for
alveolar cells. The type I alveolar cells are in close interaction
with the pulmonary capillary endothelial cells to ensure exchange
of respiratory gases. Surfactant lipids and proteins secreted by
type II epithelial cells diminish alveolar surface tension. They
ensure optimal surface tension, prevention of alveolar collapse
but ensuring elasticity and gas exchange. The type II alveolar
cells have many lipid-rich lamellar bodies, microvilli on the
apical surfaces and express surfactant homeostasis mediating
lipids and proteins, such as surfactant protein (SP)-A, SP-B,
SP-C, SP-D5. SPs bind, aggregate and/or directly kill microbial
pathogens, enhancing their clearance by immune system cells
(Numata et al., 2010; Whitsett et al., 2010). SP-A and SP-D
belong to collectins (innate host-defense proteins); they bind with
PAMPs. SP-A and SP-B form tubular myelin that together with
lipids forms a pool of surfactant and host-defense proteins (e.g.,
lysozymes and SP-C). This enhances opsonization and killing of
pathogens by alveolar macrophages and regulates macrophage,
neutrophil, and lymphocyte activity (Hartshorn, 2010; Whitsett
and Alenghat, 2015). Loss of SP-B or SP-C production impairs
both alveolar barrier and macrophage functions and causes
tissue injury and inflammation (Akei et al., 2006). The volume
and composition of surfactant pools are maintained by de
novo synthesis, reuptake and recycling by alveolar type II
cells, also by the catabolic activity of alveolar macrophages, in
processes partly regulated by granulocyte-macrophage colony-
stimulating factors (GM-CSF) (Whitsett et al., 2010; Whitsett
and Alenghat, 2015). Impairment of GM-CSF signaling has been
associated with susceptibility to bacterial and viral infections
(Tourdot et al., 2008).
Two types of macrophages can be found in the lungs,
alveolar macrophages and interstitial macrophages (Jiang and
Zhu, 2016). Macrophages can roughly be classified to classically
activated (M1) and alternatively activated (M2) macrophages,
mirroring Th1 and Th2 polarization of T cells. M1 macrophages
are induced by INFγ and LPS, they are involved in pathogen
clearance. M2 macrophages are induced by IL-4 and IL-13,
and are involved in wound healing and anti-inflammatory
responses (Sica and Mantovani, 2012; Liu et al., 2013; Shapouri-
Moghaddam et al., 2018). It is possible that M1-mediated
inflammation in the adipose tissue of obese patients enhances
M2-mediated asthmatic inflammation of the lungs (Sharma et al.,
2017). CD163 is a known marker for M2 macrophages, it seems
to have a role in airway hyperresponsiveness and asthma (Jiang
and Zhu, 2016; Tokunaga et al., 2019). Alveolar macrophages
respond to pathogens, sense antigens and activate innate and
acquired immunity. During infection, they clear apoptotic cells
and inhibit inflammation (Westphalen et al., 2014). Alveolar
epithelial cells and macrophages directly communicate via
Cnx43 channels to modify inflammatory signals and regulate
cytokine and chemokine expression in response to pathogens
(Westphalen et al., 2014; Whitsett and Alenghat, 2015).
Interventions to modulate phenotypes of alveolar macrophages
may have therapeutic potential in the treatment of asthma
(Jiang and Zhu, 2016).
Epithelial Functions in Bronchiectasis,
Primary Ciliary Dyskinesia, and Cystic
Fibrosis
Bronchiectasis results from severe airway infection and
inflammation. Its pathomechanisms are in part unknown.
Patients with bronchiectasis have irreversible bronchial dilatation
with excessive goblet cell differentiation and mucus production
(Whitsett and Alenghat, 2015). Defective airway host-defense,
infections and inflammation contribute to the development of
bronchiectasis (Guan et al., 2018).
In PCD patients, the dysfunctional movement of cilia
leads to impaired mucociliary clearance, accumulation of thick
mucus, recurrent infections, and may lead to the development
of bronchiectasis with chronic bacterial infections (Knowles
et al., 2013; Popatia et al., 2014). Chronic infections occur
both in the lower and upper airways. CRS and CRSwNP are
common in patients with bronchiectasis according to a Spanish
study (Guilemany et al., 2009). However, Chinese adults with
bronchiectasis seem to have less CRS than in western populations
(Guan et al., 2015).
Bronchiectasis is also a common manifestation of cystic
fibrosis (CF) (Guan et al., 2018). Patients with CF have
mutations in the gene encoding cystic fibrosis transmembrane
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conductance regulator (CFTR), leading to inhibition of
Cl− and HCO3− transport by airway and submucosal
gland epithelial cells. This results in thickening of mucus,
which leads to flawed mucociliary clearance, secondary
impairment in ciliary movement and chronic bacterial
infection (Whitsett and Alenghat, 2015), both in lungs and
paranasal sinuses (Hamilos, 2016). CRSwNP occurs with
increased prevalence in CF patients (Hamilos, 2016). There
is evidence that increased intracellular levels of Cl− may be
associated with chronic inflammation in bronchiectasis and CF
(Zhang et al., 2018).
There is a strong association of a homozygous mutation of
the chloride transport gene (CFTR) with childhood-onset CRS
(Kim and Ober, 2019). Heterozygous CFTR mutations are also
associated with CRS signals, albeit less than in clinical CF, with
disease usually presenting in adulthood (Hsu et al., 2013; Yoo
and Suh, 2017). The impaired mucociliary flow seen with CFTR
mutations is presumed to intensify microbial exposure, also
affecting disease course (Wang et al., 2000). The importance of
CFTR in childhood-onset CRS suggests that also other barrier-
related genes might play a role in CRS initiation.
Much of the non-protein encoding DNA encodes functional
RNAs, important in gene regulation. A microarray analysis of
bronchial brushings showed that 1,063 out of over 30,000 long
non-coding RNA transcripts had different expression between
CF and non-CF individuals, the pathologic processes in CF
patients’ airway epithelium are thus possibly partly driven by
non-coding RNAs, possibly altering gene expression regulation
(McKiernan et al., 2014).
EPITHELIUM AND UNITED AIRWAY
CONCEPT
Most genes related to viral responses were similarly induced
in upper and lower airways, in a study involving poly (I:C)
-stimulated intra-individual primary nasal and bronchial
epithelial cells, however, asthma patients had impaired
induction of several interferon-related genes (Wagener
et al., 2014). In a cross-sectional study of asthmatic children;
transcriptomic sequencing was performed in 10 children
and targeted sequencing in 40 children. Expression profiles
reassembled in nasal and bronchial brushings, were specific
to asthma independently of atopic status, and clustering
analysis identified Th2-high and low subjects differentiated
by expression of 70 genes (such as IL-13, IL-5, periostin,
CLCA1, SERPINB2) (Poole et al., 2014). These Th2-high
subjects more likely had atopy, atopic asthma, eosinophilia,
and rhinitis. Hence, using less invasive nasal brushing samples
and epithelial profiling may be clinically applicable when
assessing asthma endotype and specific treatment. There is
evidence that nasal epithelial cells could act as surrogates
to bronchial epithelial cells in studies investigating airway
inflammation (McDougall et al., 2008; Roberts et al., 2018). This
is, however, not always feasible, bronchial epithelial cells are
more susceptible to rhinovirus infection than nasal epithelial
cells (Lopez-Souza et al., 2009).
CONCLUSION AND FUTURE NEEDS
Airway epithelium has important innate immune functions,
all these functions seem to be essentially involved in the
development of AR, CRS, and asthma.
Under normal conditions, several airborne factors are inhaled
through the respiratory system and they interact with the
airway barriers. In healthy individuals, the airway barrier limits
the entry of pathogens and allergens, regulates the interaction
with the host immune system promoting homeostasis. In AR,
CRS, and asthma, barrier penetration results in inflammatory
responses that are dynamic and heterogeneous and not clearly
matched to the inciting agents. Asthma is not a single
disease entity, and childhood-onset and adult-onset asthma
have different backgrounds regarding their genetics, association
with AR and CRS, possibly also differences in microbe-
host interactions. Currently, only triggering factors of AR
and other allergic diseases are known. Of note, allergens
have an impact in pathogenesis and exacerbation of atopic
asthma, both childhood-onset and adult-onset. Development
of CRS and asthma seem to involve several triggering factors,
such as microbiome dysbiosis, which together with host
barrier immunity leads to development and aggravation of
the disease. However, it is not fully understood whether
microbiome dysbiosis is a primary or secondary event.
Microbiota changes during development, aging, sporadic events,
treatment, between anatomic compartments, and between
individuals. Well-controlled studies, and the latest methodology
are mandatory to identify putative causal relationships between
functionally active microbiota and chronic airway diseases.
Bronchial epithelial sampling is more complicated, whereas nasal
epithelial sampling can be performed easily, and with little
harm. Genome-scale experiments and genome-environmental
interaction analyses are important approaches when searching
for pathways of chronic upper airway diseases.
AUTHOR CONTRIBUTIONS
All authors participated in writing of this article and critically
reviewed the final article text.
FUNDING
The study was supported in part by research grants of Aatos
Erkko Foundation, Finnish Medical Society Duodecim, Finnish
ORL-HNS Foundation, Finnish Society of Allergology and
Immunology, State funding for university-level health research
(TYH2018103 and TYH2019322), Tampere Tuberculosis
association, Väinö and Laina Kivi Foundation, and Yrjö
Jahnsson Foundation.
ACKNOWLEDGMENTS
We wish to thank Helena Schmidt for her work with the figure.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 March 2020 | Volume 8 | Article 204
fcell-08-00204 March 25, 2020 Time: 18:38 # 10
Laulajainen-Hongisto et al. Respiratory System Epithelial Dynamics
REFERENCES
Aazami, H., Seif, F., Ghalehbaghi, B., Mohebbi, A., Ahmadi, A., Babaheidarian, P.,
et al. (2018). Levels of total IgA and IgA subclasses in the serum of chronic
rhinosinusitis patients. Med. J. Islam. Repub. Iran 32:94. doi: 10.14196/mjiri.32.
94
Ahsen, M. E., Chun, Y., Grishin, A., Grishina, G., Stolovitzky, G., Pandey, G., et al.
(2019). NeTFactor, a framework for identifying transcriptional regulators of
gene expression-based biomarkers. Sci. Rep. 9:12970. doi: 10.1038/s41598-019-
49498-y
Akei, H., Whitsett, J. A., Buroker, M., Ninomiya, T., Tatsumi, H., Weaver, T. E.,
et al. (2006). Surface tension influences cell shape and phagocytosis in alveolar
macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L572–L579.
Alevy, Y. G., Patel, A. C., Romero, A. G., Patel, D. A., Tucker, J., Roswit, W. T.,
et al. (2012). IL-13-induced airway mucus production is attenuated by MAPK13
inhibition. J. Clin. Invest. 122, 4555–4568. doi: 10.1172/JCI64896
Altman, M. C., Lai, Y., Nolin, J. D., Long, S., Chen, C. C., Piliponsky, A. M.,
et al. (2019). Airway epithelium-shifted mast cell infiltration regulates asthmatic
inflammation via IL-33 signaling. J. Clin. Invest. 129, 4979–4991. doi: 10.1172/
JCI126402
Armstrong, L., Medford, A. R., Uppington, K. M., Robertson, J., Witherden, I. R.,
Tetley, T. D., et al. (2004). Expression of functional toll-like receptor-2 and -
4 on alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 31, 241–245. doi:
10.1165/rcmb.2004-0078oc
Athari, S. S. (2019). Targeting cell signaling in allergic asthma. Signal Transduct.
Target. Ther. 4:45. doi: 10.1038/s41392-019-0079-0
Barham, H. P., Osborn, J. L., Snidvongs, K., Mrad, N., Sacks, R., and Harvey, R. J.
(2015). Remodeling changes of the upper airway with chronic rhinosinusitis.
Int. Forum Allergy Rhinol. 5, 565–572. doi: 10.1002/alr.21546
Bartel, S., La Grutta, S., Cilluffo, G., Perconti, G., Bongiovanni, A., Giallongo, A.,
et al. (2019). Human airway epithelial extracellular vesicle miRNA signature
is altered upon asthma development. Allergy 75, 346-356. doi: 10.1111/all.
14008
Batzakakis, D., Stathas, T., Mastronikolis, N., Kourousis, C., Aletras, A., and
Naxakis, S. (2014). Adhesion molecules as predictors of nasal polyposis
recurrence. Am. J. Rhinol. Allergy 28, 20–22. doi: 10.2500/ajra.2014.28.3962
Blaiss, M. S., Hammerby, E., Robinson, S., Kennedy-Martin, T., and Buchs, S.
(2018). The burden of allergic rhinitis and allergic rhinoconjunctivitis on
adolescents: a literature review. Annals Allergy Asthma Immunol. 121, 43–52.e3.
doi: 10.1016/j.anai.2018.03.028
Bou Saab, J., Losa, D., Chanson, M., and Ruez, R. (2014). Connexins in respiratory
and gastrointestinal mucosal immunity. FEBS Lett. 588, 1288–1296. doi: 10.
1016/j.febslet.2014.02.059
Bravo, D. T., Soudry, E., Edward, J. A., Le, W., Nguyen, A. L., Hwang, P. H.,
et al. (2013). Characterization of human upper airway epithelial progenitors.
Int. Forum Allergy Rhinol. 3, 841–847. doi: 10.1002/alr.21205
Busse, W. W., Lemanske, R. F. Jr., and Gern, J. E. (2010). Role of viral respiratory
infections in asthma and asthma exacerbations. Lancet 376, 826–834. doi: 10.
1016/S0140-6736(10)61380-3
Carpagnano, G. E., Scioscia, G., Lacedonia, D., Soccio, P., Lepore, G., Saetta, M.,
et al. (2018). Looking for airways periostin in severe asthma: could it be useful
for clustering type 2 endotype? Chest 154, 1083–1090. doi: 10.1016/j.chest.2018.
08.1032
Chen, X., Chang, L., Li, X., Huang, J., Yang, L., Lai, X., et al. (2018). Tc17/IL-
17A up-regulated the expression of MMP-9 via NF-kappaB pathway in nasal
epithelial cells of patients with chronic rhinosinusitis. Front. Immunol. 9:2121.
doi: 10.3389/fimmu.2018.02121
Cho, J. S., Kang, J. H., Um, J. Y., Han, I. H., Park, I. H., and Lee, H. M. (2014).
Lipopolysaccharide induces pro-inflammatory cytokines and MMP production
via TLR4 in nasal polyp-derived fibroblast and organ culture. PLoS One
9:e90683. doi: 10.1371/journal.pone.0090683
Cho, J. S., Kim, J. A., Park, J. H., Park, I. H., Han, I. H., and Lee, H. M. (2016). Toll-
like receptor 4-mediated expression of interleukin-32 via the c-Jun N-terminal
kinase/protein kinase B/cyclic adenosine monophosphate response element
binding protein pathway in chronic rhinosinusitis with nasal polyps. Int. Forum
Allergy Rhinol. 6, 1020–1028. doi: 10.1002/alr.21792
Clifford, R. L., Patel, J., MacIsaac, J. L., McEwen, L. M., Johnson, S. R., Shaw, D.,
et al. (2019). Airway epithelial cell isolation techniques affect DNA methylation
profiles with consequences for analysis of asthma related perturbations to DNA
methylation. Sci. Rep. 9:14409. doi: 10.1038/s41598-019-50873-y
Cohen, N. A. (2017). The genetics of the bitter taste receptor T2R38 in upper airway
innate immunity and implications for chronic rhinosinusitis. Laryngoscope 127,
44–51. doi: 10.1002/lary.26198
Copeland, E., Leonard, K., Carney, R., Kong, J., Forer, M., Naidoo, Y., et al.
(2018). Chronic rhinosinusitis: potential role of microbial dysbiosis and
recommendations for sampling sites. Front. Cell. Infect. Microbiol. 8:57. doi:
10.3389/fcimb.2018.00057
Cutting, G. R. (2005). Modifier genetics: cystic fibrosis. Annu. Rev. Genomics Hum.
Genet. 6, 237–260. doi: 10.1146/annurev.genom.6.080604.162254
Deng, H., Sun, Y., Wang, W., Li, M., Yuan, T., Kong, W., et al. (2019). The hippo
pathway effector Yes-associated protein promotes epithelial proliferation and
remodeling in chronic rhinosinusitis with nasal polyps. Allergy 74, 731–742.
doi: 10.1111/all.13647
Dickson, R. P., Erb-Downward, J. R., and Huffnagle, G. B. (2013). The role of
the bacterial microbiome in lung disease. Expert Rev. Respir. Med. 7, 245–257.
doi: 10.1586/ers.13.24
Dietz de Loos, D., Lourijsen, E. S., Wildeman, M. A. M., Freling, N. J. M., Wolvers,
M. D. J., Reitsma, S., et al. (2019). Prevalence of chronic rhinosinusitis in the
general population based on sinus radiology and symptomatology. J. Allergy
Clin. Immunol. 143, 1207–1214. doi: 10.1016/j.jaci.2018.12.986
Earl, J. P., Adappa, N. D., Krol, J., Bhat, A. S., Balashov, S., Ehrlich, R. L., et al.
(2018). Species-level bacterial community profiling of the healthy sinonasal
microbiome using Pacific biosciences sequencing of full-length 16S rRNA
genes. Microbiome 6:190. doi: 10.1186/s40168-018-0569-2
Ebenezer, J. A., Christensen, J. M., Oliver, B. G., Oliver, R. A., Tjin, G., Ho, J., et al.
(2017). Periostin as a marker of mucosal remodelling in chronic rhinosinusitis.
Rhinology 55, 234–241. doi: 10.4193/Rhin16.215
Ege, M. J., Mayer, M., Normand, A. C., Genuneit, J., Cookson, W. O., Braun-
Fahrlander, C., et al. (2011). Exposure to environmental microorganisms and
childhood asthma. N. Engl. J. Med. 364, 701–709. doi: 10.1056/NEJMoa1007302
El-Anwar, M. W., Hamed, A. A., Mohamed, A. E., Nofal, A. A., Mohamed,
M. A., and Abdel-Aziz, H. R. (2015). Surfactant protein a expression in chronic
rhinosinusitis and atrophic rhinitis. Int. Arch. Otorhinolaryngol. 19, 130–134.
doi: 10.1055/s-0035-1546432
Erle, D. J., and Sheppard, D. (2014). The cell biology of asthma. J. Cell Biol. 205,
621–631. doi: 10.1083/jcb.201401050
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., et al.
(2012). EPOS 2012: European position paper on rhinosinusitis and nasal polyps
2012. A summary for otorhinolaryngologists. Rhinology 50, 1–12. doi: 10.4193/
Rhino50E2
Freund, J. R., Mansfield, C. J., Doghramji, L. J., Adappa, N. D., Palmer, J. N.,
Kennedy, D. W., et al. (2018). Activation of airway epithelial bitter taste
receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-
AMP, and nitric oxide signaling. J. Biol. Chem. 293, 9824–9840. doi: 10.1074/
jbc.RA117.001005
Frohlich, M., Pinart, M., Keller, T., Reich, A., Cabieses, B., Hohmann, C., et al.
(2017). Is there a sex-shift in prevalence of allergic rhinitis and comorbid
asthma from childhood to adulthood? A meta-analysis. Clin. Transl. Allergy
7:44. doi: 10.1186/s13601-017-0176-5
Fukuoka, A., Matsushita, K., Morikawa, T., Adachi, T., Yasuda, K., Kiyonari, H.,
et al. (2019). Human cystatin SN is an endogenous protease inhibitor that
prevents allergic rhinitis. J. Allergy Clin. Immunol. 143, 1153–1162.e12. doi:
10.1016/j.jaci.2018.06.035
Georas, S. N., and Rezaee, F. (2014). Epithelial barrier function: at the front
line of asthma immunology and allergic airway inflammation. J. Allergy Clin.
Immunol. 134, 509–520. doi: 10.1016/j.jaci.2014.05.049
GINA (2018). GINA Report: Global Strategy for Asthma Management and
Prevention. Available online at: https://ginasthma.org/wp-content/uploads/
2018/04/wms-GINA-2018-report-V1.3-002.pdf (accessed November 15,
2019).
Golebski, K., Luiten, S., van Egmond, D., de Groot, E., Roschmann, K. I., Fokkens,
W. J., et al. (2014). High degree of overlap between responses to a virus and
to the house dust mite allergen in airway epithelial cells. PLoS One 9:e87768.
doi: 10.1371/journal.pone.0087768
Goto, K., Chiba, Y., Sakai, H., and Misawa, M. (2009). Tumor necrosis factor-
alpha (TNF-alpha) induces upregulation of RhoA via NF-kappaB activation in
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 March 2020 | Volume 8 | Article 204
fcell-08-00204 March 25, 2020 Time: 18:38 # 11
Laulajainen-Hongisto et al. Respiratory System Epithelial Dynamics
cultured human bronchial smooth muscle cells. J. Pharmacol. Sci. 110, 437–444.
doi: 10.1254/jphs.09081fp
Guan, W. J., Gao, Y. H., Li, H. M., Yuan, J. J., Chen, R. C., and Zhong, N. S. (2015).
Impacts of co-existing chronic rhinosinusitis on disease severity and risks of
exacerbations in Chinese adults with bronchiectasis. PLoS One 10:e0137348.
doi: 10.1371/journal.pone.0137348
Guan, W. J., Li, J. C., Liu, F., Zhou, J., Liu, Y. P., Ling, C., et al. (2018).
Next-generation sequencing for identifying genetic mutations in adults with
bronchiectasis. J. Thorac. Dis. 10, 2618–2630. doi: 10.21037/jtd.2018.04.134
Gudis, D., Zhao, K. Q., and Cohen, N. A. (2012). Acquired cilia dysfunction in
chronic rhinosinusitis. Am. J. Rhinol. Allergy 26, 1–6. doi: 10.2500/ajra.2012.
26.3716
Guilemany, J. M., Angrill, J., Alobid, I., Centellas, S., Pujols, L., Bartra, J., et al.
(2009). United airways again: high prevalence of rhinosinusitis and nasal
polyps in bronchiectasis. Allergy 64, 790–797. doi: 10.1111/j.1398-9995.2008.
01892.x
Gupta, R., Sheikh, A., Strachan, D. P., and Anderson, H. R. (2004). Burden of
allergic disease in the UK: secondary analyses of national databases. Clin. Exp.
Allergy 34, 520–526. doi: 10.1111/j.1365-2222.2004.1935.x
Hallit, S., Raherison, C., Malaeb, D., Hallit, R., Waked, M., Kheir, N., et al. (2019).
Development of an asthma risk factors scale (ARFS) for risk assessment asthma
screening in children. Pediatr. Neonatol. 60, 156–165. doi: 10.1016/j.pedneo.
2018.05.009
Hamilos, D. L. (2016). Chronic rhinosinusitis in patients with cystic fibrosis.
J. Allergy Clin. Immunol. Pract. 4, 605–612. doi: 10.1016/j.jaip.2016.04.013
Hammad, H., Chieppa, M., Perros, F., Willart, M. A., Germain, R. N., and
Lambrecht, B. N. (2009). House dust mite allergen induces asthma via Toll-
like receptor 4 triggering of airway structural cells. Nat. Med. 15, 410–416.
doi: 10.1038/nm.1946
Hanif, T., Dhaygude, K., Kankainen, M., Renkonen, J., Mattila, P., Ojala, T.,
et al. (2019). Birch pollen allergen immunotherapy reprograms nasal epithelial
transcriptome and recovers microbial diversity. J. Allergy Clin. Immunol. 143,
2293–2296.e11. doi: 10.1016/j.jaci.2019.02.002
Hansel, T. T., Johnston, S. L., and Openshaw, P. J. (2013). Microbes and mucosal
immune responses in asthma. Lancet 381, 861–873. doi: 10.1016/s0140-
6736(12)62202-8
Hartshorn, K. L. (2010). Role of surfactant protein A and D (SP-A and
SP-D) in human antiviral host defense. Front. Biosci. 2:s83. doi: 10.27
41/s83
Hirota, T., Takahashi, A., Kubo, M., Tsunoda, T., Tomita, K., Doi, S., et al. (2011).
Genome-wide association study identifies three new susceptibility loci for adult
asthma in the Japanese population. Nat. Genet. 43, 893–896. doi: 10.1038/ng.
887
Hirsch, A. G., Nordberg, C., Bandeen-Roche, K., Tan, B. K., Schleimer, R. P., Kern,
R. C., et al. (2019). Radiologic sinus inflammation and symptoms of chronic
rhinosinusitis in a population-based sample. Allergy doi: 10.1111/all.14106
[Epub ahead of print].
Hoggard, M., Wagner Mackenzie, B., Jain, R., Taylor, M. W., Biswas, K., and
Douglas, R. G. (2017). Chronic rhinosinusitis and the evolving understanding
of microbial ecology in chronic inflammatory mucosal disease. Clin. Microbiol.
Rev. 30, 321–348. doi: 10.1128/cmr.00060-16
Homma, T., Kato, A., Sakashita, M., Takabayashi, T., Norton, J. E., Suh, L. A.,
et al. (2017). Potential involvement of the epidermal growth factor receptor
ligand epiregulin and matrix metalloproteinase-1 in pathogenesis of chronic
rhinosinusitis. Am. J. Respir. Cell Mol. Biol. 57, 334–345. doi: 10.1165/rcmb.
2016-0325OC
Hsu, J., Avila, P. C., Kern, R. C., Hayes, M. G., Schleimer, R. P., and Pinto, J. M.
(2013). Genetics of chronic rhinosinusitis: state of the field and directions
forward. J. Allergy Clin. Immunol. 131, 977–993.e5. doi: 10.1016/j.jaci.2013.01.
028
Hu, H., and Li, H. (2018). Prunetin inhibits lipopolysaccharide-induced
inflammatory cytokine production and MUC5AC expression by inactivating
the TLR4/MyD88 pathway in human nasal epithelial cells. Biomed.
Pharmacother. 106, 1469–1477. doi: 10.1016/j.biopha.2018.07.093
Huang, Y. J., Nariya, S., Harris, J. M., Lynch, S. V., Choy, D. F., Arron, J. R., et al.
(2015). The airway microbiome in patients with severe asthma: associations
with disease features and severity. J. Allergy Clin. Immunol. 136, 874–884.
doi: 10.1016/j.jaci.2015.05.044
Hupin, C., Gohy, S., Bouzin, C., Lecocq, M., Polette, M., and Pilette, C. (2014).
Features of mesenchymal transition in the airway epithelium from chronic
rhinosinusitis. Allergy 69, 1540–1549. doi: 10.1111/all.12503
Ilmarinen, P., Tuomisto, L. E., and Kankaanranta, H. (2015). Phenotypes,
risk factors, and mechanisms of adult-onset asthma. Mediators Inflamm.
2015:514868. doi: 10.1155/2015/514868
Ishida, A., Ohta, N., Suzuki, Y., Kakehata, S., Okubo, K., Ikeda, H., et al.
(2012). Expression of pendrin and periostin in allergic rhinitis and chronic
rhinosinusitis. Allergol. Int. 61, 589–595. doi: 10.2332/allergolint.11-OA-0370
Jardeleza, C., Miljkovic, D., Baker, L., Boase, S., Tan, N. C., Koblar, S. A., et al.
(2013). Inflammasome gene expression alterations in Staphylococcus aureus
biofilm-associated chronic rhinosinusitis. Rhinology 51, 315–322. doi: 10.4193/
Rhin13.045
Jarvis, D., Newson, R., Lotvall, J., Hastan, D., Tomassen, P., Keil, T., et al. (2012).
Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN
survey in Europe. Allergy 67, 91–98. doi: 10.1111/j.1398-9995.2011.02709.x
Jiang, Z., and Zhu, L. (2016). Update on the role of alternatively activated
macrophages in asthma. J. Asthma Allergy 9, 101–107. doi: 10.2147/JAA.
S104508
Jiao, J., Duan, S., Meng, N., Li, Y., Fan, E., and Zhang, L. (2015). Role of IFN-
gamma, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells
in chronic rhinosinusitis with nasal polyps. Clin. Exp. Allergy 46, 449–460.
doi: 10.1111/cea.12644
Jiao, J., Wang, C., and Zhang, L. (2019). Epithelial physical barrier defects in
chronic rhinosinusitis. Expert Rev. Clin. Immunol. 15, 679–688. doi: 10.1080/
1744666X.2019.1601556
Jiao, J., Wang, M., Duan, S., Meng, Y., Meng, N., Li, Y., et al. (2018). Transforming
growth factor-beta1 decreases epithelial tight junction integrity in chronic
rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. 141, 1160–1163.e9.
doi: 10.1016/j.jaci.2017.08.045
Joenvaara, S., Mattila, P., Renkonen, J., Makitie, A., Toppila-Salmi, S., Lehtonen,
M., et al. (2009). Caveolar transport through nasal epithelium of birch pollen
allergen Bet v 1 in allergic patients. J. Allergy Clin. Immunol. 124, 135–142.e1-21.
doi: 10.1016/j.jaci.2008.11.048
Juhn, Y. J. (2014). Risks for infection in patients with asthma (or other atopic
conditions): is asthma more than a chronic airway disease? J. Allergy Clin.
Immunol. 134, 247–257: quiz 58–59.
Juncadella, I. J., Kadl, A., Sharma, A. K., Shim, Y. M., Hochreiter-Hufford, A.,
Borish, L., et al. (2013). Apoptotic cell clearance by bronchial epithelial cells
critically influences airway inflammation. Nature 493, 547–551. doi: 10.1038/
nature11714
Kaur, R., and Chupp, G. (2019). Phenotypes and endotypes of adult asthma:
moving toward precision medicine. J. Allergy Clin. Immunol. 144, 1–12. doi:
10.1016/j.jaci.2019.05.031
Khlifi, R., Olmedo, P., Gil, F., Hammami, B., and Hamza-Chaffai, A. (2015).
Cadmium and nickel in blood of Tunisian population and risk of nasosinusal
polyposis disease. Environ. Sci. Pollut. Res. 22, 3586–3593. doi: 10.1007/s11356-
014-3619-8
Kim, B., Lee, H. J., Im, N. R., Lee, D. Y., Kang, C. Y., Park, I. H., et al. (2018).
Effect of matrix metalloproteinase inhibitor on disrupted E-cadherin after acid
exposure in the human nasal epithelium. Laryngoscope 128, E1–E7. doi: 10.
1002/lary.26932
Kim, K. W., and Ober, C. (2019). Lessons learned from GWAS of asthma. Allergy
Asthma Immunol. Res. 11, 170–187.
Kim, R., Chang, G., Hu, R., Phillips, A., and Douglas, R. (2016). Connexin gap
junction channels and chronic rhinosinusitis. Int. Forum Allergy Rhinol. 6,
611–617. doi: 10.1002/alr.21717
Knight, R., Vrbanac, A., Taylor, B. C., Aksenov, A., Callewaert, C., Debelius, J.,
et al. (2018). Best practices for analysing microbiomes. Nat. Rev. Microbiol. 16,
410–422. doi: 10.1038/s41579-018-0029-9
Knowles, M. R., Daniels, L. A., Davis, S. D., Zariwala, M. A., and Leigh, M. W.
(2013). Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and
characterization of clinical disease. Am. J. Respir. Crit. Care Med. 188, 913–922.
doi: 10.1164/rccm.201301-0059CI
Kohanski, M. A., Workman, A. D., Patel, N. N., Hung, L.-Y., Shtraks, J. P., Chen,
B., et al. (2018). Solitary chemosensory cells are a primary epithelial source of
IL-25 in patients with chronic rhinosinusitis with nasal polyps. J. Allergy Clin.
Immunol. 142, 460–469.e7. doi: 10.1016/j.jaci.2018.03.019
Frontiers in Cell and Developmental Biology | www.frontiersin.org 11 March 2020 | Volume 8 | Article 204
fcell-08-00204 March 25, 2020 Time: 18:38 # 12
Laulajainen-Hongisto et al. Respiratory System Epithelial Dynamics
Kountakis, S. E., Arango, P., Bradley, D., Wade, Z. K., and Borish, L. (2004).
Molecular and cellular staging for the severity of chronic rhinosinusitis.
Laryngoscope 114, 1895–1905. doi: 10.1097/01.mlg.0000147917.43615.c0
Kouzaki, H., Matsumoto, K., Kato, T., Tojima, I., Shimizu, S., and Shimizu, T.
(2016). Epithelial cell-derived cytokines contribute to the pathophysiology of
eosinophilic chronic rhinosinusitis. J. Interferon Cytokine Res. 36, 169–179.
doi: 10.1089/jir.2015.0058
Kristjansson, R. P., Benonisdottir, S., Davidsson, O. B., Oddsson, A., Tragante, V.,
Sigurdsson, J. K., et al. (2019). A loss-of-function variant in ALOX15 protects
against nasal polyps and chronic rhinosinusitis. Nat. Genet. 51, 267–276. doi:
10.1038/s41588-018-0314-6
Kudo, M., Ishigatsubo, Y., and Aoki, I. (2013). Pathology of asthma. Front.
Microbiol. 4:263.
Kuhar, H. N., Tajudeen, B. A., Mahdavinia, M., Gattuso, P., Ghai, R., and Batra,
P. S. (2017). Inflammatory infiltrate and mucosal remodeling in chronic
rhinosinusitis with and without polyps: structured histopathologic analysis. Int.
Forum Allergy Rhinol. 7, 679–689. doi: 10.1002/alr.21943
Lal, D., Keim, P., Delisle, J., Barker, B., Rank, M. A., Chia, N., et al. (2017).
Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy,
allergic rhinitis, and chronic rhinosinusitis subjects. Int. Forum Allergy Rhinol.
7, 561–569. doi: 10.1002/alr.21934
Lam, K., Schleimer, R., and Kern, R. C. (2015). The etiology and pathogenesis of
chronic rhinosinusitis: a review of current hypotheses. Curr. Allergy Asthma
Rep. 15:41. doi: 10.1007/s11882-015-0540-2
Lambrecht, B. N., and Hammad, H. (2012). The airway epithelium in asthma. Nat.
Med. 18, 684–692. doi: 10.1038/nm.2737
Lambrecht, B. N., and Hammad, H. (2014). Allergens and the airway epithelium
response: gateway to allergic sensitization. J. Allergy Clin. Immunol. 134, 499–
507. doi: 10.1016/j.jaci.2014.06.036
Lan, B., Mitchel, J. A., O’Sullivan, M. J., Park, C. Y., Kim, J. H., Cole, W. C.,
et al. (2018). Airway epithelial compression promotes airway smooth muscle
proliferation and contraction. Am. J. Physiol. Lung Cell. Mol. Physiol. 315,
L645–L652. doi: 10.1152/ajplung.00261.2018
Laury, A. M., Hilgarth, R., Nusrat, A., and Wise, S. K. (2015). Periostin and
receptor activator of nuclear factor kappa-B ligand expression in allergic fungal
rhinosinusitis. Int. Forum Allergy Rhinol. 4, 716–724. doi: 10.1002/alr.21367
Lee, R. J., and Cohen, N. A. (2014). Bitter and sweet taste receptors in the
respiratory epithelium in health and disease. J. Mol. Med. 92, 1235–1244. doi:
10.1007/s00109-014-1222-6
Lehmann, A. E., Scangas, G. A., Bergmark, R. W., El Rassi, E., Stankovic, K. M.,
and Metson, R. (2019). Periostin and inflammatory disease: implications for
chronic rhinosinusitis. Otolaryngol. Head Neck Surg. 160, 965–973. doi: 10.
1177/0194599819838782
Li, J., and Li, Y. (2019). Autophagy is involved in allergic rhinitis by inducing airway
remodeling. Int. Forum Allergy Rhinol. 9, 1346–1351. doi: 10.1002/alr.22424
Li, X., Tao, Y., and Li, X. (2015). Expression of MMP-9/TIMP-2 in nasal polyps and
its functional implications. Int. J. Clin. Exp. Pathol. 8, 14556–14561.
Li, Y., Wang, X., Wang, R., Bo, M., Fan, E., Duan, S., et al. (2014). The expression
of epithelial intercellular junctional proteins in the sinonasal tissue of subjects
with chronic rhinosinusitis: a histopathologic study. ORL J. Otorhinolaryngol.
Relat. Spec. 76, 110–119. doi: 10.1159/000362246
Li, Y. Y., Li, C. W., Chao, S. S., Yu, F. G., Yu, X. M., Liu, J., et al. (2014). Impairment
of cilia architecture and ciliogenesis in hyperplastic nasal epithelium from nasal
polyps. J. Allergy Clin. Immunol. 134, 1282–1292. doi: 10.1016/j.jaci.2014.07.
038
Li, Z., Zeng, M., Deng, Y., Zhao, J., Zhou, X., Trudeau, J. B., et al. (2019). 15-
Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through
extracellular signal-regulated kinase activation. J. Allergy Clin. Immunol. 144,
1228–1241.e9. doi: 10.1016/j.jaci.2019.06.037
Liao, B., Hu, C. Y., Liu, T., and Liu, Z. (2014). Respiratory viral infection in the
chronic persistent phase of chronic rhinosinusitis. Laryngoscope 124, 832–837.
doi: 10.1002/lary.24348
Licona-Limon, P., Kim, L. K., Palm, N. W., and Flavell, R. A. (2013). TH2, allergy
and group 2 innate lymphoid cells. Nat. Immunol. 14, 536–542. doi: 10.1038/ni.
2617
Lin, H., Li, Z., Lin, D., Zheng, C., and Zhang, W. (2016). Role of NLRP3
inflammasome in eosinophilic and non-eosinophilic chronic rhinosinusitis
with nasal polyps. Inflammation 39, 2045–2052. doi: 10.1007/s10753-016-
0442-z
Lisspers, K., Janson, C., Larsson, K., Johansson, G., Telg, G., Thuresson, M., et al.
(2018). Comorbidity, disease burden and mortality across age groups in a
Swedish primary care asthma population: an epidemiological register study
(PACEHR). Respir. Med. 136, 15–20. doi: 10.1016/j.rmed.2018.01.020
Liu, C., Li, Y., Yu, J., Feng, L., Hou, S., Liu, Y., et al. (2013). Targeting the shift from
M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice
treated with fasudil. PLoS One 8:e54841. doi: 10.1371/journal.pone.0054841
London, N. R. Jr., and Ramanathan, M. Jr. (2017). The role of the sinonasal
epithelium in allergic rhinitis. Otolaryngol. Clin. North Am. 50, 1043–1050.
doi: 10.1016/j.otc.2017.08.002
Lopez-Souza, N., Favoreto, S., Wong, H., Ward, T., Yagi, S., Schnurr, D., et al.
(2009). In vitro susceptibility to rhinovirus infection is greater for bronchial
than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol.
123, 1384–1390.e2. doi: 10.1016/j.jaci.2009.03.010
Luukkainen, A., Puan, K. J., Yusof, N., Lee, B., Tan, K. S., Liu, J., et al. (2018). A co-
culture model of PBMC and stem cell derived human nasal epithelium reveals
rapid activation of NK and innate T cells upon influenza A virus infection of
the nasal epithelium. Front. Immunol. 9:2514. doi: 10.3389/fimmu.2018.02514
Ma, Y., Sun, Y., Jiang, L., Zuo, K., Chen, H., Guo, J., et al. (2017). WDPCP regulates
the ciliogenesis of human sinonasal epithelial cells in chronic rhinosinusitis.
Cytoskeleton 74, 82–90. doi: 10.1002/cm.21351
Maeda, Y., Chen, G., Xu, Y., Haitchi, H. M., Du, L., Keiser, A. R., et al. (2011).
Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell
metaplasia and Th2 inflammation. Am. J. Respir. Crit. Care Med. 184, 421–429.
doi: 10.1164/rccm.201101-0106OC
Malinsky, R. R., Valera, F. C., Cavallari, F. E., Kupper, D. S., Milaneze, C., Silva, J. S.,
et al. (2013). Matrix metalloproteinases and their impact on sinusal extension
in chronic rhinosinusitis with nasal polyps. Eur. Arch. Otorhinolaryngol. 270,
1345–1348. doi: 10.1007/s00405-012-2219-9
Martin, F. J., and Prince, A. S. (2008). TLR2 regulates gap junction intercellular
communication in airway cells. J. Immunol. 180, 4986–4993. doi: 10.4049/
jimmunol.180.7.4986
Mattila, P., Renkonen, J., Toppila-Salmi, S., Parviainen, V., Joenvaara, S., Alff-
Tuomala, S., et al. (2010). Time-series nasal epithelial transcriptomics during
natural pollen exposure in healthy subjects and allergic patients. Allergy 65,
175–183. doi: 10.1111/j.1398-9995.2009.02181.x
McDougall, C. M., Blaylock, M. G., Douglas, J. G., Brooker, R. J., Helms, P. J., and
Walsh, G. M. (2008). Nasal epithelial cells as surrogates for bronchial epithelial
cells in airway inflammation studies. Am. J. Respir. Cell Mol. Biol. 39, 560–568.
doi: 10.1165/rcmb.2007-0325OC
McKiernan, P. J., Molloy, K., Cryan, S. A., McElvaney, N. G., and Greene, C. M.
(2014). Long noncoding RNA are aberrantly expressed in vivo in the cystic
fibrosis bronchial epithelium. Int. J. Biochem. Cell Biol. 52, 184–191. doi: 10.
1016/j.biocel.2014.02.022
Mésidor, M., Benedetti, A., El-Zein, M., Menzies, D., Parent, M. -É, and Rousseau,
M.-C. (2019). Asthma phenotypes based on health services use for allergic
diseases in a province-wide birth cohort. Ann. Allergy Asthma Immunol. 122,
50–57.e2. doi: 10.1016/j.anai.2018.09.453
Milonski, J., Zielinska-Blizniewska, H., Przybylowska, K., Pietkiewicz, P.,
Korzycka-Zaborowska, B., Majsterek, I., et al. (2015). Significance of
CYCLOOXYGENASE-2(COX-2), PERIOSTIN (POSTN) and INTERLEUKIN-
4(IL-4) gene expression in the pathogenesis of chronic rhinosinusitis with nasal
polyps. Eur. Arch. Otorhinolaryngol. 272, 3715–3720. doi: 10.1007/s00405-014-
3481-9
Monick, M. M., Yarovinsky, T. O., Powers, L. S., Butler, N. S., Carter, A. B.,
Gudmundsson, G., et al. (2003). Respiratory syncytial virus up-regulates TLR4
and sensitizes airway epithelial cells to endotoxin. J. Biol. Chem. 278, 53035–
53044. doi: 10.1074/jbc.m308093200
Morris, A., Beck, J. M., Schloss, P. D., Campbell, T. B., Crothers, K., Curtis, J. L.,
et al. (2013). Comparison of the respiratory microbiome in healthy nonsmokers
and smokers. Am. J. Respir. Crit. Care Med. 187, 1067–1075.
Muluk, N. B., Arikan, O. K., Atasoy, P., Kilic, R., and Yalcinozan, E. T. (2015).
The role of MMP-2, MMP-9, and TIMP-1 in the pathogenesis of nasal polyps:
immunohistochemical assessment at eight different levels in the epithelial,
subepithelial, and deep layers of the mucosa. Ear Nose Throat J. 94, E1–E13.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 12 March 2020 | Volume 8 | Article 204
fcell-08-00204 March 25, 2020 Time: 18:38 # 13
Laulajainen-Hongisto et al. Respiratory System Epithelial Dynamics
Numata, M., Chu, H. W., Dakhama, A., and Voelker, D. R. (2010). Pulmonary
surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced
inflammation and infection. Proc. Natl. Acad. Sci. USA 107, 320–325. doi:
10.1073/pnas.0909361107
Nunes, C., Pereira, A. M., and Morais-Almeida, M. (2017). Asthma costs and social
impact. Asthma Res. Pract. 3:1.
Ohta, N., Ishida, A., Kurakami, K., Suzuki, Y., Kakehata, S., Ono, J., et al. (2014).
Expressions and roles of periostin in otolaryngological diseases. Allergol. Int. 63,
171–180. doi: 10.2332/allergolint.13-RAI-0673
Ordovas-Montanes, J., Dwyer, D. F., Nyquist, S. K., Buchheit, K. M., Vukovic, M.,
Deb, C., et al. (2018). Allergic inflammatory memory in human respiratory
epithelial progenitor cells. Nature 560, 649–654. doi: 10.1038/s41586-01
8-0449-8
Osorio, F., Lambrecht, B., and Janssens, S. (2013). The UPR and lung disease.
Semin. Immunopathol. 35, 293–306. doi: 10.1007/s00281-013-0368-6
Oyer, S. L., Nagel, W., and Mulligan, J. K. (2013). Differential expression
of adhesion molecules by sinonasal fibroblasts among control and chronic
rhinosinusitis patients. Am. J. Rhinol. Allergy 27, 381–386. doi: 10.2500/ajra.
2013.27.3934
Pace, E., Ferraro, M., Siena, L., Melis, M., Montalbano, A. M., Johnson, M.,
et al. (2008). Cigarette smoke increases Toll-like receptor 4 and modifies
lipopolysaccharide-mediated responses in airway epithelial cells. Immunology
124, 401–411. doi: 10.1111/j.1365-2567.2007.02788.x
Pallasaho, P., Ronmark, E., Haahtela, T., Sovijarvi, A. R., and Lundback, B. (2006).
Degree and clinical relevance of sensitization to common allergens among
adults: a population study in Helsinki, Finland. Clin. Exp. Allergy 36, 503–509.
doi: 10.1111/j.1365-2222.2006.02460.x
Park, S. K., Jin, S. Y., Yeon, S. H., Lee, S. B., Xu, J., Yoon, Y. H., et al. (2018). Role of
Toll-like receptor 9 signaling on activation of nasal polyp-derived fibroblasts
and its association with nasal polypogenesis. Int. Forum Allergy Rhinol. 8,
1001–1012. doi: 10.1002/alr.22155
Peric, A., Mirkovic, C. S., and Vojvodic, D. (2018). Clara cell protein 16 release
from the nasal mucosa in allergic rhinitis, chronic rhinosinusitis, and exposure
to air pollutants. Arh. Hig. Rada. Toksikol. 69, 215–219. doi: 10.2478/aiht-2018-
69-3081
Peterson, S., Poposki, J. A., Nagarkar, D. R., Chustz, R. T., Peters, A. T., Suh,
L. A., et al. (2012). Increased expression of CC chemokine ligand 18 in patients
with chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. 129,
119–127.e1–9. doi: 10.1016/j.jaci.2011.08.021
Pividori, M., Schoettler, N., Nicolae, D. L., Ober, C., and Im, H. K. (2019). Shared
and distinct genetic risk factors for childhood-onset and adult-onset asthma:
genome-wide and transcriptome-wide studies. Lancet Respir. Med. 7, 509–522.
doi: 10.1016/S2213-2600(19)30055-4
Polosa, R., and Thomson, N. C. (2013). Smoking and asthma: dangerous liaisons.
Eur. Respir. J. 41, 716–726. doi: 10.1183/09031936.00073312
Pols, D. H. J., Wartna, J. B., Moed, H., van Alphen, E. I., Bohnen, A. M., and Bindels,
P. J. E. (2016). Atopic dermatitis, asthma and allergic rhinitis in general practice
and the open population: a systematic review. Scand. J. Prim. Health Care 34,
143–150. doi: 10.3109/02813432.2016.1160629
Poole, A., Urbanek, C., Eng, C., Schageman, J., Jacobson, S., O’Connor, B. P., et al.
(2014). Dissecting childhood asthma with nasal transcriptomics distinguishes
subphenotypes of disease. J. Allergy Clin. Immunol. 133, 670–678.e12. doi:
10.1016/j.jaci.2013.11.025
Popatia, R., Haver, K., and Casey, A. (2014). Primary ciliary dyskinesia: an update
on new diagnostic modalities and review of the literature. Pediatr. Allergy
Immunol. Pulmonol. 27, 51–59. doi: 10.1089/ped.2013.0314
Pothoven, K. L., Norton, J. E., Hulse, K. E., Suh, L. A., Carter, R. G., Rocci, E., et al.
(2015). Oncostatin M promotes mucosal epithelial barrier dysfunction, and its
expression is increased in patients with eosinophilic mucosal disease. J. Allergy
Clin. Immunol. 136, 737–746.e4. doi: 10.1016/j.jaci.2015.01.043
Pothoven, K. L., and Schleimer, R. P. (2017). The barrier hypothesis and oncostatin
M: restoration of epithelial barrier function as a novel therapeutic strategy
for the treatment of type 2 inflammatory disease. Tissue Barriers 5:e1341367.
doi: 10.1080/21688370.2017.1341367
Ramezanpour, M., Moraitis, S., Smith, J. L., Wormald, P. J., and Vreugde, S. (2016).
Th17 cytokines disrupt the airway mucosal barrier in chronic rhinosinusitis.
Mediators Inflamm. 2016:9798206. doi: 10.1155/2016/9798206
Rehl, R. M., Balla, A. A., Cabay, R. J., Hearp, M. L., Pytynia, K. B., and Joe,
S. A. (2007). Mucosal remodeling in chronic rhinosinusitis. Am. J. Rhinol. 21,
651–657. doi: 10.2500/ajr.2007.21.3096
Renkonen, J., Toppila-Salmi, S., Joenvaara, S., Mattila, P., Parviainen, V.,
Hagstrom, J., et al. (2015). Expression of Toll-like receptors in nasal epithelium
in allergic rhinitis. APMIS 123, 716–725. doi: 10.1111/apm.12408
Roberts, N., Al Mubarak, R., Francisco, D., Kraft, M., and Chu, H. W. (2018).
Comparison of paired human nasal and bronchial airway epithelial cell
responses to rhinovirus infection and IL-13 treatment. Clin. Transl. Med. 7:13.
doi: 10.1186/s40169-018-0189-2
Roschmann, K. I., Luiten, S., Jonker, M. J., Breit, T. M., Fokkens, W. J., Petersen,
A., et al. (2011). Timothy grass pollen extract-induced gene expression and
signalling pathways in airway epithelial cells. Clin. Exp. Allergy 41, 830–841.
doi: 10.1111/j.1365-2222.2011.03713.x
Roscioli, E., Jersmann, H. P., Lester, S., Badiei, A., Fon, A., Zalewski, P., et al. (2017).
Zinc deficiency as a codeterminant for airway epithelial barrier dysfunction in
an ex vivo model of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 3503–3510.
doi: 10.2147/COPD.S149589
Ryu, G., and Kim, D. W. (2020). Th2 inflammatory responses in the development
of nasal polyps and chronic rhinosinusitis. Curr. Opin. Allergy Clin. Immunol.
20, 1–8. doi: 10.1097/aci.0000000000000588
Saulyte, J., Regueira, C., Montes-Martinez, A., Khudyakov, P., and Takkouche, B.
(2014). Active or passive exposure to tobacco smoking and allergic rhinitis,
allergic dermatitis, and food allergy in adults and children: a systematic
review and meta-analysis. PLoS Med. 11:e1001611. doi: 10.1371/journal.pmed.
1001611
Scadding, G. (2014). Cytokine profiles in allergic rhinitis. Curr. Allergy Asthma
Rep.o 14:435.
Schleimer, R. P. (2017). Immunopathogenesis of chronic rhinosinusitis and
nasal polyposis. Annu. Rev. Pathol. 12, 331–357. doi: 10.1146/annurev-pathol-
052016-100401
Schleimer, R. P., and Berdnikovs, S. (2017). Etiology of epithelial barrier
dysfunction in patients with type 2 inflammatory diseases. J. Allergy Clin.
Immunol. 139, 1752–1761. doi: 10.1016/j.jaci.2017.04.010
Schoettler, N., Rodriguez, E., Weidinger, S., and Ober, C. (2019). Advances in
asthma and allergic disease genetics – is bigger always better? J. Allergy Clin.
Immunol.144, 1495-1506. doi: 10.1016/j.jaci.2019.10.023
Seshadri, S., Lin, D. C., Rosati, M., Carter, R. G., Norton, J. E., Suh, L., et al. (2012).
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of
patients with chronic rhinosinusitis. Allergy 67, 920–928. doi: 10.1111/j.1398-
9995.2012.02848.x
Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili,
S. A., Mardani, F., et al. (2018). Macrophage plasticity, polarization, and
function in health and disease. J. Cell. Physiol. 233, 6425–6440. doi: 10.1002/
jcp.26429
Sharma, N., Akkoyunlu, M., and Rabin, R. L. (2017). Macrophages-common culprit
in obesity and asthma. Allergy. 73, 1196–1205. doi: 10.1111/all.13369
Shi, L. L., Xiong, P., Zhang, L., Cao, P. P., Liao, B., Lu, X., et al. (2013). Features
of airway remodeling in different types of Chinese chronic rhinosinusitis are
associated with inflammation patterns. Allergy 68, 101–109. doi: 10.1111/all.
12064
Shimizu, S., Kouzaki, H., Kato, T., Tojima, I., and Shimizu, T. (2016). HMGB1-
TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8
by nasal epithelial cells. Am. J. Rhinol. Allergy 30, 167–172. doi: 10.2500/ajra.
2016.30.4300
Shimizu, S., Ogawa, T., Takezawa, K., Tojima, I., Kouzaki, H., and Shimizu, T.
(2015). Tissue factor and tissue factor pathway inhibitor in nasal mucosa and
nasal secretions of chronic rhinosinusitis with nasal polyp. Am. J. Rhinol. Allergy
29, 235–242. doi: 10.2500/ajra.2015.29.4183
Shimizu, S., Tojima, I., Takezawa, K., Matsumoto, K., Kouzaki, H., and Shimizu,
T. (2017). Thrombin and activated coagulation factor X stimulate the release
of cytokines and fibronectin from nasal polyp fibroblasts via protease-activated
receptors. Am. J. Rhinol. Allergy 31, 13–18. doi: 10.2500/ajra.2017.31.4400
Shin, S. H., Kim, Y. H., Jin, H. S., and Kang, S. H. (2016a). Alternaria induces
production of thymic stromal lymphopoietin in nasal fibroblasts through toll-
like receptor 2. Allergy Asthma Immunol. Res. 8, 63–68. doi: 10.4168/aair.2016.
8.1.63
Frontiers in Cell and Developmental Biology | www.frontiersin.org 13 March 2020 | Volume 8 | Article 204
fcell-08-00204 March 25, 2020 Time: 18:38 # 14
Laulajainen-Hongisto et al. Respiratory System Epithelial Dynamics
Shin, S. H., Ye, M. K., Kim, Y. H., and Kim, J. K. (2016b). Role of TLRs in the
production of chemical mediators in nasal polyp fibroblasts by fungi. Auris
Nasus Larynx 43, 166–170. doi: 10.1016/j.anl.2015.07.003
Shiono, O., Sakuma, Y., Komatsu, M., Hirama, M., Yamashita, Y., Ishitoya, J., et al.
(2015). Differential expression of periostin in the nasal polyp may represent
distinct histological features of chronic rhinosinusitis. Auris Nasus Larynx 42,
123–127. doi: 10.1016/j.anl.2014.09.003
Sica, A., and Mantovani, A. (2012). Macrophage plasticity and polarization: in vivo
veritas. J. Clin. Invest. 122, 787–795. doi: 10.1172/JCI59643
Sigurs, N., Bjarnason, R., Sigurbergsson, F., and Kjellman, B. (2000). Respiratory
syncytial virus bronchiolitis in infancy is an important risk factor for asthma
and allergy at age 7. Am. J. Respir. Crit. Care Med. 161, 1501–1507. doi:
10.1164/ajrccm.161.5.9906076
Soyka, M. B., Wawrzyniak, P., Eiwegger, T., Holzmannm, D., Treis, A., Wanke, K.,
et al. (2012). Defective epithelial barrier in chronic rhinosinusitis: the regulation
of tight junctions by IFN-gamma and IL-4. J. Allergy Clin. Immunol. 130,
1087–1096.e10. doi: 10.1016/j.jaci.2012.05.052
Stentzel, S., Teufelberger, A., Nordengrun, M., Kolata, J., Schmidt, F., van
Crombruggen, K., et al. (2017). Staphylococcal serine protease-like proteins are
pacemakers of allergic airway reactions to Staphylococcus aureus. J. Allergy Clin.
Immunol. 139, 492–500.e8. doi: 10.1016/j.jaci.2016.03.045
Sterner, T., Uldahl, A., Svensson, A., Bjork, J., Svedman, C., Nielsen, C., et al. (2019).
The southern Sweden adolescent allergy-cohort: prevalence of allergic diseases
and cross-sectional associations with individual and social factors. J. Asthma 56,
227–235. doi: 10.1080/02770903.2018.1452033
Sun, Y., Zhou, B., Wang, C., Huang, Q., Zhang, Q., Han, Y., et al. (2012).
Biofilm formation and Toll-like receptor 2, Toll-like receptor 4, and NF-kappaB
expression in sinus tissues of patients with chronic rhinosinusitis. Am. J. Rhinol.
Allergy 26, 104–109. doi: 10.2500/ajra.2012.26.3718
Suzuki, H., Koizumi, H., Ikezaki, S., Tabata, T., Ohkubo, J., Kitamura, T., et al.
(2016). Electrical impedance and expression of tight junction components of
the nasal turbinate and polyp. ORL J. Otorhinolaryngol. Relat. Spec. 78, 16–25.
doi: 10.1159/000442024
Suzuki, M., Itoh, M., Ohta, N., Nakamura, Y., Moriyama, A., Matsumoto, T., et al.
(2006). Blocking of protease allergens with inhibitors reduces allergic responses
in allergic rhinitis and other allergic diseases. Acta Otolaryngol. 126, 746–751.
doi: 10.1080/00016480500475625
Suzuki, M., Ramezanpour, M., Cooksley, C., Li, J., Nakamaru, Y., Homma, A.,
et al. (2018). Sirtuin-1 controls Poly (I:C)-dependent matrix metalloproteinase
9 activation in primary human nasal epithelial cells. Am. J. Respir. Cell Mol. Biol.
59, 500–510. doi: 10.1165/rcmb.2017-0415OC
Takabayashi, T., Kato, A., Peters, A. T., Hulse, K. E., Suh, L. A., Carter, R.,
et al. (2013). Excessive fibrin deposition in nasal polyps caused by fibrinolytic
impairment through reduction of tissue plasminogen activator expression. Am.
J. Respir. Crit. Care Med. 187, 49–57. doi: 10.1164/rccm.201207-1292OC
Takabayashi, T., Tanaka, Y., Susuki, D., Yoshida, K., Tomita, K., Sakashita, M.,
et al. (2019). Increased expression of L-plastin in nasal polyp of patients with
nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. Allergy
74, 1307–1316. doi: 10.1111/all.13677
Tan, A. M., Chen, H. C., Pochard, P., Eisenbarth, S. C., Herrick, C. A., and
Bottomly, H. K. (2010). TLR4 signaling in stromal cells is critical for the
initiation of allergic Th2 responses to inhaled antigen. J. Immunol. 184, 3535–
3544. doi: 10.4049/jimmunol.0900340
Tengroth, L., Arebro, J., Kumlien Georen, S., Winqvist, O., and Cardell, L. O.
(2014a). Deprived TLR9 expression in apparently healthy nasal mucosa might
trigger polyp-growth in chronic rhinosinusitis patients. PLoS One 9:e105618.
doi: 10.1371/journal.pone.0105618
Tengroth, L., Millrud, C. R., Kvarnhammar, A. M., Kumlien Georen, S., Latif, L.,
and Cardell, L. O. (2014b). Functional effects of Toll-like receptor (TLR)3, 7,
9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS One 9:e98239.
doi: 10.1371/journal.pone.0098239
Thai, P., Loukoianov, A., Wachi, S., and Wu, R. (2008). Regulation of airway
mucin gene expression. Annu. Rev. Physiol. 70, 405–429. doi: 10.1146/annurev.
physiol.70.113006.100441
Tharakan, A., Halderman, A. A., Lane, A. P., Biswal, S., and Ramanathan, M.
Jr. (2016). Reversal of cigarette smoke extract-induced sinonasal epithelial cell
barrier dysfunction through Nrf2 Activation. Int. Forum Allergy Rhinol. 6,
1145–1150. doi: 10.1002/alr.21827
Tieu, D. D., Peters, A. T., Carter, R. G., Suh, L., Conley, D. B., Chandra, R., et al.
(2010). Evidence for diminished levels of epithelial psoriasin and calprotectin
in chronic rhinosinusitis. J. Allergy Clin. Immunol. 125, 667–675. doi: 10.1016/
j.jaci.2009.11.045
Tipirneni, K. E., Zhang, S., Cho, D. Y., Grayson, J., Skinner, D. F., Mackey, C.,
et al. (2018). Submucosal gland mucus strand velocity is decreased in chronic
rhinosinusitis. Int. Forum Allergy Rhinol. 8, 509–512. doi: 10.1002/alr.22065
Tokunaga, Y., Imaoka, H., Kaku, Y., Kawayama, T., and Hoshino, T. (2019). The
significance of CD163-expressing macrophages in asthma. Ann. Allergy Asthma
Immunol. 123, 263–270. doi: 10.1016/j.anai.2019.05.019
Tomassen, P., Vandeplas, G., Van Zele, T., Cardell, L. O., Arebro, J., Olze, H.,
et al. (2016). Inflammatory endotypes of chronic rhinosinusitis based on cluster
analysis of biomarkers. J. Allergy Clin. Immunol. 137, 1449–1456.e4. doi: 10.
1016/j.jaci.2015.12.1324
Tomaszewska, M., Sarnowska, E., Rusetska, N., Kowalik, K., Sierdzinski, J.,
Siedlecki, J. A., et al. (2019). Role of vitamin D and its receptors in the
pathophysiology of chronic rhinosinusitis. J. Am. Coll. Nutr. 38, 108–118. doi:
10.1080/07315724.2018.1503102
Toppila-Salmi, S., Chanoine, S., Karjalainen, J., Pekkanen, J., Bousquet, J., and
Siroux, V. (2019). Risk of adult-onset asthma increases with the number of
allergic multimorbidities and decreases with age. Allergy 74, 2406–2416. doi:
10.1111/all.13971
Toppila-Salmi, S., van Drunen, C. M., Fokkens, W. J., Golebski, K., Mattila, P.,
Joenvaara, S., et al. (2015). Molecular mechanisms of nasal epithelium in rhinitis
and rhinosinusitis. Curr. Allergy Asthma Rep. 15:495.
Toskala, E., and Kennedy, D. W. (2015). Asthma risk factors. Int. Forum Allergy
Rhinol. 5(Suppl. 1), S11–S16.
Tourdot, S., Mathie, S., Hussell, T., Edwards, L., Wang, H., Openshaw, P. J., et al.
(2008). Respiratory syncytial virus infection provokes airway remodelling in
allergen-exposed mice in absence of prior allergen sensitization. Clin. Exp.
Allergy 38, 1016–1024. doi: 10.1111/j.1365-2222.2008.02974.x
Tsai, Y. J., Chi, J. C., Hao, C. Y., and Wu, W. B. (2018). Peptidoglycan
induces bradykinin receptor 1 expression through Toll-like receptor 2 and
NF-kappaB signaling pathway in human nasal mucosa-derived fibroblasts of
chronic rhinosinusitis patients. J. Cell. Physiol. 233, 7226–7238. doi: 10.1002/jcp.
26553
Tsybikov, N. N., Egorova, E. V., Kuznik, B. I., Fefelova, E. V., and Magen, E.
(2016). Biomarker assessment in chronic rhinitis and chronic rhinosinusitis:
endothelin-1, TARC/CCL17, neopterin, and alpha-defensins. Allergy Asthma
Proc. 37, 35–42. doi: 10.2500/aap.2016.37.3899
Tyner, J. W., Kim, E. Y., Ide, K., Pelletier, M. R., Roswit, W. T., Morton,
J. D., et al. (2006). Blocking airway mucous cell metaplasia by inhibiting
EGFR antiapoptosis and IL-13 transdifferentiation signals. J. Clin. Invest. 116,
309–321. doi: 10.1172/jci25167
Van Bruaene, N., and Bachert, C. (2011). Tissue remodeling in chronic
rhinosinusitis. Curr. Opin. Allergy Clin. Immunol. 11, 8–11. doi: 10.1097/aci.
0b013e32834233ef
Vercelli, D., and Bleecker, E. R. (2019). Strength in numbers: the quest for
asthma genes. J. Allergy Clin. Immunol. 144, 413–415. doi: 10.1016/j.jaci.2019.
06.007
Vonk, J. M., Nieuwenhuis, M. A. E., Dijk, F. N., Boudier, A., Siroux, V., Bouzigon,
E., et al. (2018). Novel genes and insights in complete asthma remission: a
genome-wide association study on clinical and complete asthma remission.
Clin. Exp. Allergy 48, 1286–1296. doi: 10.1111/cea.13181
Voynow, J. A., and Rubin, B. K. (2009). Mucins, mucus, and sputum. Chest 135,
505–512. doi: 10.1378/chest.08-0412
Wagener, A. H., Zwinderman, A. H., Luiten, S., Fokkens, W. J., Bel, E. H., Sterk,
P. J., et al. (2014). dsRNA-induced changes in gene expression profiles of
primary nasal and bronchial epithelial cells from patients with asthma, rhinitis
and controls. Respir. Res. 15:9. doi: 10.1186/1465-9921-15-9
Wang, L. F., Chien, C. Y., Chiang, F. Y., Chai, C. Y., and Tai, C. F. (2012).
Corelationship between matrix metalloproteinase 2 and 9 expression and
severity of chronic rhinosinusitis with nasal polyposis. Am. J. Rhinol. Allergy
26, e1–e4. doi: 10.2500/ajra.2012.26.3724
Wang, M., Wang, X., Zhang, N., Wang, H., Li, Y., Fan, E., et al. (2015).
Association of periostin expression with eosinophilic inflammation in nasal
polyps. J. Allergy Clin. Immunol. 136, 1700–1703.e9. doi: 10.1016/j.jaci.2015.
09.005
Frontiers in Cell and Developmental Biology | www.frontiersin.org 14 March 2020 | Volume 8 | Article 204
fcell-08-00204 March 25, 2020 Time: 18:38 # 15
Laulajainen-Hongisto et al. Respiratory System Epithelial Dynamics
Wang, X., Moylan, B., Leopold, D. A., Kim, J., Rubenstein, R. C., Togias,
A., et al. (2000). Mutation in the gene responsible for cystic fibrosis and
predisposition to chronic rhinosinusitis in the general population. JAMA 284,
1814–1819.
Wei, Y., Ma, R., Zhang, J., Wu, X., Yu, G., Hu, X., et al. (2018). Excessive periostin
expression and Th2 response in patients with nasal polyps: association with
asthma. J. Thorac. Dis. 10, 6585–6597. doi: 10.21037/jtd.2018.11.12
Wenzel, S. E. (2012). Asthma phenotypes: the evolution from clinical to molecular
approaches. Nat. Med. 18, 716–725. doi: 10.1038/nm.2678
Westphalen, K., Gusarova, G. A., Islam, M. N., Subramanian, M., Cohen, T. S.,
Prince, A. S., et al. (2014). Sessile alveolar macrophages communicate with
alveolar epithelium to modulate immunity. Nature 506, 503–506. doi: 10.1038/
nature12902
Whitsett, J. A., and Alenghat, T. (2015). Respiratory epithelial cells orchestrate
pulmonary innate immunity. Nat. Immunol. 16, 27–35. doi: 10.1038/ni.
3045
Whitsett, J. A., Wert, S. E., and Weaver, T. E. (2010). Alveolar surfactant
homeostasis and the pathogenesis of pulmonary disease. Annu. Rev. Med. 61,
105–119. doi: 10.1146/annurev.med.60.041807.123500
Wiksten, J., Toppila-Salmi, S., and Makela, M. (2018). Primary prevention of
airway allergy. Curr. Treat. Options Allergy 5, 347–355. doi: 10.1007/s40521-
018-0190-4
Willis-Owen, S. A. G., Cookson, W. O. C., and Moffatt, M. F. (2018). The genetics
and genomics of asthma. Annu. Rev. Genomics Hum. Genet. 19, 223–246. doi:
10.1146/annurev-genom-083117-021651
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., et al. (2018).
International consensus statement on allergy and rhinology: allergic rhinitis.
Int. Forum Allergy Rhinol. 8, 108–352.
Wu, D., Wei, Y., and Bleier, B. S. (2018). Emerging role of proteases in the
pathogenesis of chronic rhinosinusitis with nasal polyps. Front. Cell. Infect.
Microbiol. 7:538. doi: 10.3389/fcimb.2017.00538
Xiang, R., Zhang, Q. P., Zhang, W., Kong, Y. G., Tan, L., Chen, S. M., et al. (2019).
Different effects of allergic rhinitis on nasal mucosa remodeling in chronic
rhinosinusitis with and without nasal polyps. Eur. Arch. Otorhinolaryngol. 276,
115–130. doi: 10.1007/s00405-018-5195-x
Xu, J., Lee, J. W., Park, S. K., Lee, S. B., Yoon, Y. H., Yeon, S. H., et al. (2014). Toll-
like receptor 9 ligands increase type I interferon induced B-cell activating factor
expression in chronic rhinosinusitis with nasal polyposis. Clin. Immunol. 197,
19–26. doi: 10.1016/j.clim.2018.07.014
Xu, M., Chen, D., Zhou, H., Zhang, W., Xu, J., and Chen, L. (2017). The role of
periostin in the occurrence and progression of eosinophilic chronic sinusitis
with nasal polyps. Sci. Rep. 7:9479. doi: 10.1038/s41598-017-08375-2
Yamin, M., Holbrook, E. H., Gray, S. T., Busaba, N. Y., Lovett, B., and Hamilos,
D. L. (2015). Profibrotic transforming growth factor beta 1 and activin A
are increased in nasal polyp tissue and induced in nasal polyp epithelium by
cigarette smoke and Toll-like receptor 3 ligation. Int. Forum Allergy Rhinol. 5,
573–582. doi: 10.1002/alr.21516
Yang, H. W., Park, J. H., Shin, J. M., and Lee, H. M. (2018). Glucocorticoids
ameliorate periostin-induced tissue remodeling in chronic rhinosinusitis with
nasal polyps. Clin. Exp. Allergy 10, 10. doi: 10.1111/cea.13267 [Epub ahead of
print].
Yang, L. Y., Li, X., Li, W. T., Huang, J. C., Wang, Z. Y., Huang, Z. Z., et al. (2017).
Vgamma1+ gammadeltaT cells are correlated with increasing expression of
eosinophil cationic protein and metalloproteinase-7 in chronic rhinosinusitis
with nasal polyps inducing the formation of edema. Allergy Asthma Immunol.
Res. 9, 142–151. doi: 10.4168/aair.2017.9.2.142
Yeo, N. K., Eom, D. W., Oh, M. Y., Lim, H. W., and Song, Y. J. (2013). Expression
of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 1
in nonrecurrent vs recurrent nasal polyps. Ann. Allergy Asthma Immunol. 111,
205–210. doi: 10.1016/j.anai.2013.06.023
Yilmaz, O. H., Katajisto, P., Lamming, D. W., Gultekin, Y., Bauer-Rowe, K. E.,
Sengupta, S., et al. (2012). mTORC1 in the Paneth cell niche couples intestinal
stem-cell function to calorie intake. Nature 486, 490–495. doi: 10.1038/
nature11163
Yoo, F., and Suh, J. D. (2017). What is the evidence for genetics in chronic
rhinosinusitis? Curr. Opin. Otolaryngol. Head Neck Surg. 25, 54–63. doi: 10.
1097/MOO.0000000000000329
Yu, X. M., Li, C. W., Li, Y. Y., Liu, J., Lin, Z. B., Li, T. Y., et al. (2013). Down-
regulation of EMP1 is associated with epithelial hyperplasia and metaplasia in
nasal polyps. Histopathology 63, 686–695. doi: 10.1111/his.12211
Zhang, Y. L., Chen, P. X., Guan, W. J., Guo, H. M., Qiu, Z. E., Xu, J. W., et al. (2018).
Increased intracellular Cl concentration promotes ongoing inflammation in
airway epithelium. Mucosal Immunol. 11, 1149–1157. doi: 10.1038/s41385-018-
0013-8
Conflict of Interest: ST-S has acted as paid consultant for ERT and Roche
Products. RK has acted as a consultant for Sanofi-Regeneron, GSK, Genentech,
Astellas, Lyra Therapeutics. All these are outside the submitted work.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2020 Laulajainen-Hongisto, Toppila-Salmi, Luukkainen and Kern.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 15 March 2020 | Volume 8 | Article 204
